
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><title>Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing - de la Hoya - 2001 - International Journal of Cancer - Wiley Online Library</title><meta name="robots" content="noarchive" /><meta http-equiv="X-UA-Compatible" content="IE=7,IE=9,IE=10,chrome=1" /><!-- START Google Scholar --><meta xmlns="http://www.w3.org/1999/xhtml" name="article_references" content="de la Hoya, Miguel,Osorio, Ana,Godino, Javier,Sulleiro, Sara,Tosar, Alicia,Perez&#x2010;Segura, Pedro,Fernandez, Cristina,Rodr&iacute;guez, Raquel,D&iacute;az&#x2010;Rubio, Eduardo,Ben&iacute;tez, Javier,Devilee, Peter,Cald&eacute;s, Trinidad,2002,Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing,International Journal of Cancer,97:466-471,doi:10.1002/ijc.1627." /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_abstract_html_url" content="http://onlinelibrary.wiley.com/doi/10.1002/ijc.1627/abstract" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author" content="de la Hoya, Miguel" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author_institution" content="Laboratory of Molecular Oncology, Hospital Universitario San Carlos, Madrid, Spain" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author" content="Osorio, Ana" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author_institution" content="National Center of Cancer (CNIO), Madrid, Spain" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author" content="Godino, Javier" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author_institution" content="Laboratory of Molecular Oncology, Hospital Universitario San Carlos, Madrid, Spain" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author" content="Sulleiro, Sara" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author_institution" content="Laboratory of Molecular Oncology, Hospital Universitario San Carlos, Madrid, Spain" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author" content="Tosar, Alicia" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author_institution" content="Laboratory of Molecular Oncology, Hospital Universitario San Carlos, Madrid, Spain" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author" content="Perez&#x2010;Segura, Pedro" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author_institution" content="Department of Medical Oncology, Hospital Universitario San Carlos, Madrid, Spain" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author" content="Fernandez, Cristina" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author_institution" content="Department of Preventive Medicine, Hospital Universitario San Carlos, Madrid, Spain" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author" content="Rodr&iacute;guez, Raquel" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author_institution" content="National Center of Cancer (CNIO), Madrid, Spain" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author" content="D&iacute;az&#x2010;Rubio, Eduardo" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author_institution" content="Department of Medical Oncology, Hospital Universitario San Carlos, Madrid, Spain" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author" content="Ben&iacute;tez, Javier" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author_institution" content="National Center of Cancer (CNIO), Madrid, Spain" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author" content="Devilee, Peter" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author_institution" content="Department of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author" content="Cald&eacute;s, Trinidad" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author_institution" content="Laboratory of Molecular Oncology, Hospital Universitario San Carlos, Madrid, Spain" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_author_institution" content="Laboratory of Molecular Oncology, Hospital Universitario San Carlos, c/ Martin Lagos s/n, 28040 Madrid, Spain" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_doi" content="10.1002/ijc.1627" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_firstpage" content="466" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_fulltext_html_url" content="http://onlinelibrary.wiley.com/doi/10.1002/ijc.1627/full" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_issn" content="1097-0215" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_issue" content="4" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_journal_title" content="International Journal of Cancer" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_keywords" content="BRCA1" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_keywords" content="BRCA2" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_keywords" content="logistic regression model" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_language" content="en" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_lastpage" content="471" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_online_date" content="2001/10/18" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_pdf_url" content="http://onlinelibrary.wiley.com/doi/10.1002/ijc.1627/pdf" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_publication_date" content="2002/02/01" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_publisher" content="John Wiley &amp; Sons, Inc." /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_title" content="Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing" /><meta xmlns="http://www.w3.org/1999/xhtml" name="citation_volume" content="97" /><!-- END Google Scholar --><link rel="stylesheet" type="text/css" media="screen" href="http://onlinelibrarystatic.wiley.com/css/importAll.css" /><!--<link rel="stylesheet" type="text/css" media="screen" href="http://onlinelibrarystatic.wiley.com/css/funcChemArticle.css" />--><link rel="stylesheet" type="text/css" media="screen" href="http://onlinelibrarystatic.wiley.com/css/chosen.css" /><link rel="stylesheet" type="text/css" media="print" href="http://onlinelibrarystatic.wiley.com/css/print.css" /><!--[if IE 6]>
 <link rel="stylesheet" href="http://onlinelibrarystatic.wiley.com/css/ie6.css" type="text/css" media="screen,print" />
 <link rel="stylesheet" href="http://onlinelibrarystatic.wiley.com/css/simpleForm_ie6.css" type="text/css" media="screen,print" />
 <![endif]--><!--[if IE 7]>
 <link rel="stylesheet" href="http://onlinelibrarystatic.wiley.com/css/ie7.css" type="text/css" media="screen" />
 <link rel="stylesheet" href="http://onlinelibrarystatic.wiley.com/css/simpleForm_ie7.css" type="text/css" media="screen,print" />
 <![endif]--><script type="text/javascript" xml:space="preserve">
 document.documentElement.className = "js_en";
 </script><link rel="stylesheet" type="text/css" media="screen,print" href="http://onlinelibrarystatic.wiley.com/css/fullText.css" /><script type="text/javascript" xml:space="preserve">
 function RightslinkPopUp(url)
 { 
 window.open(url,"Rightslink","location=no,toolbar=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=yes,width=650,height=550");
 } 
 </script></head><body><div id="skip"><a href="#content" shape="rect">Skip to Main Content</a></div><div id="leftBorder"> <div id="rightBorder"> <div id="leaderBoard"> <script language="JavaScript" src="http://ad.uk.doubleclick.net/adj/wly.onco.radthr_000091/ij-cancer_IJC;tile=1;pos=1;sz=728x90;doi=101002ijc1627;ord=2039552662?" type="text/javascript" xml:space="preserve">
 </script> <noscript><a href="http://ad.uk.doubleclick.net/jump/wly.onco.radthr_000091/ij-cancer_IJC;tile=1;pos=1;sz=728x90;doi=101002ijc1627;ord=2039552662?" target="_blank" shape="rect">
 <img src="http://ad.uk.doubleclick.net/ad/wly.onco.radthr_000091/ij-cancer_IJC;tile=1;pos=1;sz=728x90;doi=101002ijc1627;ord=2039552662?" border="0" alt="" />

 </a></noscript> </div><div id="header"> <!-- globalHeaderMenu.ftl --> <div id="globalMenu"> <a href="/" title="return to home page" shape="rect"><img src="http://onlinelibrarystatic.wiley.com/images/siteLogo.gif" alt="Wiley Online Library" id="siteLogo" /></a> <p> <a href="/" id="home" shape="rect">Home</a> <a href="http://onlinelibrary.custhelp.com" id="help" shape="rect">Help</a> </p> <div> <ul><li><a href="/browse/publications" shape="rect">PUBLICATIONS</a></li><li><a href="/browse/subjects" shape="rect">BROWSE BY SUBJECT</a></li><li><a href="http://olabout.wiley.com/WileyCDA/Section/id-390229.html" shape="rect">RESOURCES</a></li><li><a href="http://olabout.wiley.com/WileyCDA/Section/id-390001.html" shape="rect">ABOUT US</a></li></ul> </div> </div> <!-- languageSwitch.ftl --> <div id="coBranding"> </div> <div id="login"> <form method="post" action="/j_spring_security_check" id="loginForm" enctype="application/x-www-form-urlencoded"><fieldset> <legend>LOGIN</legend> <div id="loginInFormInner"> <label id="emailLabel" for="loginEmail" class="hide">Enter e-mail address</label> <input type="text" name="j_username" id="loginEmail" value="" /> <div> <label id="passwordLabel" for="loginPassword" class="hide">Enter password</label> <input type="password" id="loginPassword" value="" name="j_password" /> <input name="submit" id="loginSubmit" type="image" src="http://onlinelibrarystatic.wiley.com/images/loginSubmit.png" value="Go" alt="Login" /> </div> <input type="checkbox" name="_spring_security_remember_me" id="loginRememberMe" checked="checked" /> <label for="loginRememberMe">REMEMBER ME</label> </div> </fieldset></form> <ul id="loginOptions"><li><a href="/user-registration" shape="rect">NOT REGISTERED ?</a></li><li><a href="/user/forgottenpassword" id="forgottenPassword" shape="rect">FORGOTTEN PASSWORD ?</a></li><li><a href="/login-options" shape="rect">INSTITUTIONAL LOGIN &gt;</a></li></ul> <p class="message"> </p> </div> </div> <div id="breadcrumb"> <ul xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns="http://www.w3.org/1999/xhtml"><li><a href="/" shape="rect">Home</a> &gt; </li><li><a href="/subject/code/000091" shape="rect">Oncology &amp; Radiotherapy</a> &gt; </li><li><a href="/subject/code/MDH0/titles" shape="rect">Oncology &amp; Radiotherapy</a> &gt; </li><li><a href="/journal/10.1002/(ISSN)1097-0215" shape="rect">International Journal of Cancer</a> &gt; </li><li><a href="/doi/10.1002/ijc.v97:4/issuetoc" shape="rect">Vol 97 Issue 4</a> &gt; </li><li><a href="/doi/10.1002/ijc.1627/abstract" shape="rect">Abstract</a></li></ul> </div> <div id="pageNavAndTools"> <div class="menuGroup"> <h2>JOURNAL TOOLS</h2> <ul class="titleTools"><li> <a href="/getEmailAlert?id=10.1002%2F%28ISSN%291097-0215&amp;originUrl=%2Fdoi%2F10.1002%2Fijc.1627%2Ffull" class="getEmailAlerts track-click authReq" data-t-sc="{'linkTrackVars':'events', 'linkTrackEvents':'event15', 'events':'event15'}" shape="rect">Get New Content Alerts</a> </li><li> <a class="rss" href="/rss/journal/10.1002/(ISSN)1097-0215" shape="rect">Get RSS feed</a> </li><li> <a href="/saveTitle?id=10.1002%2F%28ISSN%291097-0215&amp;type=JOURNAL&amp;originUrl=%2Fdoi%2F10.1002%2Fijc.1627%2Ffull" class="saveToProfile" shape="rect">Save to My Profile</a> </li><li> <a href="/doi/10.1002/ijc.v132.1/issuetoc" class="getSampleCopy track-click" data-t-sc="{'linkTrackVars':'events', 'linkTrackEvents':'event18', 'events':'event18'}" shape="rect">Get Sample Copy</a> </li><li> <a class="recommendToLibrarian" href="/recommend/to/librarian/doi/10.1002/(ISSN)1097-0215" shape="rect">Recommend to Your Librarian</a> </li></ul> </div> <div xmlns="http://www.w3.org/1999/xhtml" class="menuGroup"><h2>JOURNAL MENU</h2><ul><li><a href="/journal/10.1002/(ISSN)1097-0215" shape="rect">Journal Home</a></li></ul></div><div xmlns="http://www.w3.org/1999/xhtml" class="menuGroup"><h3>FIND ISSUES</h3><ul><li><a href="/journal/10.1002/(ISSN)1097-0215/currentissue" id="currentIssueLink" shape="rect">Current Issue</a></li><li><a href="/journal/10.1002/(ISSN)1097-0215/issues" shape="rect">All Issues</a></li></ul></div> <div class="menuGroup"> <h3>FIND ARTICLES</h3> <ul><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/earlyview" id="earlyViewLink" shape="rect">Early View</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/accepted" id="acceptedArticlesLink" shape="rect">Accepted Articles</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/editor_s_choice.htm" shape="rect">Editors' Choice</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/special_sections.htm" shape="rect">Special Sections</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/MostAccessed.html" shape="rect">Most Accessed</a></li></ul> </div> <div class="menuGroup"> <h3>GET ACCESS</h3> <ul><li> <a href="http://ordering.onlinelibrary.wiley.com/subs.asp?ref=1097-0215&amp;doi=10.1002/(ISSN)1097-0215" shape="rect">Subscribe / Renew</a> </li></ul> </div> <div class="menuGroup"> <h3>FOR CONTRIBUTORS</h3> <ul><li xmlns="http://www.w3.org/1999/xhtml"><a href="http://wileyonlinelibrary.com/onlineopen" shape="rect">OnlineOpen</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/ForAuthors.html" shape="rect">Author Guidelines</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="http://mc.manuscriptcentral.com/ijc-wiley" shape="rect">Submit an Article</a></li></ul> </div> <div class="menuGroup"> <h3>ABOUT THIS JOURNAL</h3> <ul><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/ProductInformation.html" shape="rect">Overview</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/EditorialBoard.html" shape="rect">Editorial Board</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/Permissions.html" shape="rect">Permissions</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/Advertise.html" shape="rect">Advertise</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/Contact.html" shape="rect">Contact</a></li></ul> </div> <div class="menuGroup"> <h2>SPECIAL FEATURES</h2> <ul><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/IJC_Lecture_Poster.pdf" shape="rect">Joint IJC &amp; Klaus Tschira Stiftung Lectureship 2013</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/article_spotlight.htm" shape="rect">Spotlights</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/professional_opportunities.htm" shape="rect">Professional Opportunities</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="http://www.wileyjobnetwork.com" shape="rect">Wiley Job Network</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/past_ijc_lectureship_videos.htm" shape="rect">Past IJC Lectureship Videos</a></li><li xmlns="http://www.w3.org/1999/xhtml"><a href="/journal/10.1002/(ISSN)1097-0215/homepage/Jobs.html" shape="rect">Jobs</a></li></ul> </div> <script language="JavaScript" src="http://ad.uk.doubleclick.net/adj/wly.onco.radthr_000091/ij-cancer_IJC;tile=2;pos=1;sz=160x600,160x320,160x160,120x600;doi=101002ijc1627;ord=2039552662?" type="text/javascript" xml:space="preserve"></script> <noscript><a href="http://ad.uk.doubleclick.net/jump/wly.onco.radthr_000091/ij-cancer_IJC;tile=2;pos=1;sz=160x600,160x320,160x160,120x600; doi=101002ijc1627;ord=2039552662?" target="_blank" shape="rect">
 <img src="http://ad.uk.doubleclick.net/ad/wly.onco.radthr_000091/ij-cancer_IJC;tile=2;pos=1;sz=160x600,160x320,160x160,120x600; doi=101002ijc1627;ord=2039552662?" border="0" alt="" />
 </a></noscript> <script language="JavaScript" src="http://ad.uk.doubleclick.net/adj/wly.onco.radthr_000091/ij-cancer_IJC;tile=4;sz=160X700;doi=101002ijc1627;ord=2039552662?" type="text/javascript" xml:space="preserve"></script> <noscript><a href="http://ad.uk.doubleclick.net/jump/wly.onco.radthr_000091/ij-cancer_IJC;tile=4;sz=160X700; doi=101002ijc1627;ord=2039552662?" target="_blank" shape="rect">
 <img src="http://ad.uk.doubleclick.net/ad/wly.onco.radthr_000091/ij-cancer_IJC;tile=4;sz=160X700; doi=101002ijc1627;ord=2039552662?" border="0" alt="" />
 </a></noscript> </div> <div id="content"> <div xmlns="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" id="banner" style="background-image: url('http://onlinelibrary.wiley.com/store/10.1002/(ISSN)1097-0215/asset/olbannerwallpaper.jpg?v=1&amp;s=2adbcfb7786fd2fae65b8e05a3c150a8f78d4c5e')"><img class="left" src="http://onlinelibrary.wiley.com/store/10.1002/(ISSN)1097-0215/asset/olbannerleft.jpg?v=1&amp;s=45719cd7de57873027993264fcc568b335a8cd56" alt="" /><img class="right" src="http://onlinelibrary.wiley.com/store/10.1002/(ISSN)1097-0215/asset/olbannerright.jpg?v=1&amp;s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19" alt="" /></div> <div id="mainContent"> <div xmlns="http://www.w3.org/1999/xhtml" class="citation articleInformationHeader" id="titleMeta"><div id="articleDesc"><p class="articleCategory">Cancer Genetics</p><div id="articleTitle"><span class="freeAccess" title="You have full text access to this OnlineOpen article">You have full text access to this OnlineOpen article</span><h1 class="articleTitle"><span class="mainTitle">Association between <em>BRCA1</em> and <em>BRCA2</em> mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing</span></h1></div><div id="articleMeta"><ol id="authors"><li id="au1">Miguel de la Hoya<sup>1</sup>, </li><li id="au2">Ana Osorio<sup>2</sup>, </li><li id="au3">Javier Godino<sup>1</sup>, </li><li id="au4">Sara Sulleiro<sup>1</sup>, </li><li id="au5">Alicia Tosar<sup>1</sup>, </li><li id="au6">Pedro Perez-Segura<sup>3</sup>, </li><li id="au7">Cristina Fernandez<sup>4</sup>, </li><li id="au8">Raquel Rodr&iacute;guez<sup>2</sup>, </li><li id="au9">Eduardo D&iacute;az-Rubio<sup>3</sup>, </li><li id="au10">Javier Ben&iacute;tez<sup>2</sup>, </li><li id="au11">Peter Devilee<sup>5</sup>, </li><li id="au12">Trinidad Cald&eacute;s<sup>1,&dagger;,*</sup></li></ol><p id="publishedOnlineDate">Article first published online: 18 OCT 2001</p><p id="doi">DOI:&nbsp;10.1002/ijc.1627</p><p id="copyright" class="copyright">Copyright &copy; 2002 Wiley-Liss, Inc.</p></div><div id="articleParent"><p class="articleCategory"> Issue </p><div id="cover" class="journal"><div class="imgShadow"><img src="http://onlinelibrary.wiley.com/store/10.1002/(ISSN)1097-0215/asset/cover.gif?v=1&amp;s=9bea5e55449dab2cff7ad3b06277cc9745417a23" alt="International Journal of Cancer" title="International Journal of Cancer" /></div></div><div id="metaData"><h2 id="productTitle">International Journal of Cancer</h2><div id="issueDetails"><p class="articleDetails"><a href="/doi/10.1002/ijc.v97:4/issuetoc" shape="rect"><span id="volumeNumber">Volume 97</span>, <span id="issueNumber">Issue 4</span>, </a> <span id="issuePages">pages 466&ndash;471</span>, <span id="issueDate">1 February 2002</span></p></div></div></div></div><div id="additionalInformation"><p class="articleCategory">Additional Information</p><div style="clear: left;"><div id="howToCite"><h4>How to Cite</h4><p id="citation">de la Hoya, M., Osorio, A., Godino, J., Sulleiro, S., Tosar, A., Perez-Segura, P., Fernandez, C., Rodr&iacute;guez, R., D&iacute;az-Rubio, E., Ben&iacute;tez, J., Devilee, P. and Cald&eacute;s, T. (2002), Association between <em>BRCA1</em> and <em>BRCA2</em> mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing. Int. J. Cancer, 97:&nbsp;466&ndash;471. doi:&nbsp;10.1002/ijc.1627</p></div><div id="authorsDetail"><h4>Author Information</h4><ol id="authorsAffiliations"><li class="affiliation"><sup>1</sup><p>Laboratory of Molecular Oncology, Hospital Universitario San Carlos, Madrid, Spain</p></li><li class="affiliation"><sup>2</sup><p>National Center of Cancer (CNIO), Madrid, Spain</p></li><li class="affiliation"><sup>3</sup><p>Department of Medical Oncology, Hospital Universitario San Carlos, Madrid, Spain</p></li><li class="affiliation"><sup>4</sup><p>Department of Preventive Medicine, Hospital Universitario San Carlos, Madrid, Spain</p></li><li class="affiliation"><sup>5</sup><p>Department of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands</p></li></ol><ol id="footnotes" class="noteGroup custom"><li id="fn1"><span class="bullet"><sup>&dagger;</sup></span><div class="text"><p>Fax: +34-91-330-3544</p></div></li></ol><p id="contactDetails"><span class="email-label">Email: </span><span class="email">Trinidad Cald&eacute;s (tcaldes@hcsc.es)</span></p><p id="correspondence"><sup>*</sup>Laboratory of Molecular Oncology, Hospital Universitario San Carlos, c/ Martin Lagos s/n, 28040 Madrid, Spain</p></div><div id="publicationHistoryDetails"><h4>Publication History</h4><ol><li>Issue published online: 29 DEC 2001</li><li>Article first published online: 18 OCT 2001</li><li>Manuscript Accepted: 8 AUG 2001</li><li>Manuscript Revised: 31 JUL 2001/li><li>Manuscript Received: 21 MAY 2001</li></ol></div><div id="fundingInfo" class="fundingInfo"><h4>Funded by</h4><ul><li>Aventis, Comunidad de Madrid. Grant Number: 08.1/0015/1998</li><li>Fondo Investigacion Sanitaria (FIS). Grant Numbers: 99/0262, 99/0140</li></ul></div></div></div></div> </div> <div id="promosAndTools"> <form method="post" action="/advanced/search/results" id="searchSite" class="searchForm" name="advancedSearchForm" enctype="application/x-www-form-urlencoded"><fieldset> <h2>SEARCH</h2> <div class="searchCriteria"> <label for="scope">Search Scope</label> <select id="scope" name="scope"><option value="allContent">All content</option><option value="publicationTitles">Publication titles</option><option value="journal">In this journal</option><option value="issue" selected="selected">In this issue</option></select> <div> <label for="searchText">Search String</label> <input type="text" id="searchText" name="query" /> <input name="searchSubmit2" id="searchSiteSubmit" type="image" src="http://onlinelibrarystatic.wiley.com/images/searchSubmit.png" value="Go" alt="Search" /> </div> <input type="hidden" value="10.1002/ijc.1627" name="publicationDoi" /> <input type="hidden" value="10.1002/ijc.v97:4" name="issueDoi" /> <input type="hidden" value="10.1002/(ISSN)1097-0215" name="titleDoi" /> <input type="hidden" value="1" name="start" /> <input type="hidden" value="20" name="resultsPerPage" /> </div> </fieldset><ul class="extraSearchOptions"><li><a href="/advanced/search" shape="rect">Advanced &gt;</a></li><li><a href="/myprofile/displaySavedSearches" shape="rect">Saved Searches &gt;</a></li></ul></form> <form method="post" action="/search/citation/results" id="searchByCitation" class="searchForm" name="citationSearchForm" enctype="application/x-www-form-urlencoded"><fieldset> <h2>SEARCH BY CITATION</h2> <div class="searchCriteria"> <div class="volume"> <label for="volume">Volume:</label> <input type="text" id="volume" name="volume" value="" class="searchVolume" /> </div> <div class="issue"> <label for="issue">Issue:</label> <input type="text" id="issue" name="issue" value="" class="searchIssue" /> </div> <div class="page"> <label for="page">Page:</label> <input type="text" id="page" name="page" value="" class="searchPage" /> </div> <input name="citationSearchSubmit" id="citationSearchSubmit" type="image" src="http://onlinelibrarystatic.wiley.com/images/searchSubmit.gif" value="Go" alt="Search" /> </div> <input type="hidden" id="publicationDoi" name="publicationDoi" value="10.1002/(ISSN)1097-0215" /> </fieldset></form> <div xmlns:w="http://www.wiley.com/namespaces/wiley" class="menuGroup"><h2>ARTICLE TOOLS</h2><ul class="titleTools"><li class="pdf"><a href="/doi/10.1002/ijc.1627/pdf" title="Article in pdf format" id="journalToolsPdfLink" shape="rect">Get PDF (86K)</a></li><li class="save"><a href="/saveContent?doi=10.1002%2Fijc.1627&amp;originUrl=%2Fdoi%2F10.1002%2Fijc.1627%2Ffull" shape="rect">Save to My Profile</a></li><li class="email"><a href="/emailArticleLink?doi=10.1002/ijc.1627&amp;issueDoi=10.1002/ijc.v97:4" shape="rect">E-mail Link to this Article</a></li><li class="citation"><a href="/documentcitationdownload?publicationDoi=10.1002/(ISSN)1097-0215&amp;doi=10.1002/ijc.1627&amp;type=journal" shape="rect">Export Citation for this Article</a></li><li><a class="getEmailAlerts authReq" href="/getCitationAlert?id=10.1002%2Fijc.1627&amp;originUrl=%2Fdoi%2F10.1002%2Fijc.1627%2Ffull" shape="rect">Get Citation Alerts</a></li><li class="requestPermissions"><a href="JavaScript:RightslinkPopUp('https://s100.copyright.com/AppDispatchServlet?publisherName=Wiley&amp;publication=IJC&amp;title=Association%20between%20BRCA1%20and%20BRCA2%20mutations%20and%20cancer%20phenotype%20in%20Spanish%20breast%2Fovarian%20cancer%20families%3A%20Implications%20for%20genetic%20testing&amp;publicationDate=18%20OCT%202001&amp;author=Miguel%20de%20la%20Hoya%2CAna%20Osorio%2CJavier%20Godino%2CSara%20Sulleiro%2CAlicia%20Tosar%2CPedro%20Perez-Segura%2CCristina%20Fernandez%2CRaquel%20Rodr%C3%ADguez%2CEduardo%20D%C3%ADaz-Rubio%2CJavier%20Ben%C3%ADtez%2CPeter%20Devilee%2CTrinidad%20Cald%C3%A9s&amp;startPage=466&amp;endPage=471&amp;copyright=Copyright%20%C2%A9%202002%20Wiley-Liss%2C%20Inc.&amp;contentID=10.1002%2Fijc.1627&amp;orderSource=Wileyonline&amp;orderBeanReset=true')" shape="rect">Request Permissions</a></li></ul></div> </div> <div id="productContent"> <div xmlns="http://www.w3.org/1999/xhtml" class="tabbedContent"><ul><li><a href="/doi/10.1002/ijc.1627/abstract" title="Link to article abstract" shape="rect">Abstract</a></li><li class="active"><span>Article</span></li><li><a href="/doi/10.1002/ijc.1627/references" title="Link to article references" shape="rect">References</a></li><li><a href="/doi/10.1002/ijc.1627/citedby" title="Other articles that have cited this article" shape="rect">Cited By</a></li></ul></div> <div xmlns:doc="urn://wiley-online-library/content/document" xmlns="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" class="viewFullArticleAndPdf"><div class="viewFullArticleAndPdfOptions"><a href="/doi/10.1002/ijc.1627/pdf" title="Article in pdf format" class="pdfLink" shape="rect">Get PDF (86K)</a></div></div> <div xmlns="http://www.w3.org/1999/xhtml" id="fulltext" class="none"><div class="keywords"><h3 class="keywordsHeading">Keywords:</h3><div class="keywordLists"><ul class="keywordList" id="abstractKeywords1"><li><em>BRCA1</em>;</li><li><em>BRCA2</em>;</li><li>logistic regression model</li></ul></div></div><div id="abstract" class="fullTextAbstract"><div class="headingCont"><h3>Abstract</h3></div><ol class="jumpList"><li><a href="#leftBorder" shape="rect">Top of page</a></li><li><a href="#abstract" shape="rect">Abstract</a></li><li><a href="#sec1-1" shape="rect">MATERIAL AND METHODS</a></li><li><a href="#sec1-2" shape="rect">RESULTS</a></li><li><a href="#sec1-3" shape="rect">DISCUSSION</a></li><li><a href="#sec1-ack-1" shape="rect">Acknowledgements</a></li><li><a href="#wol-references" shape="rect">REFERENCES</a></li></ol><div class="para"><p>Index cases from a clinically relevant cohort of 102 Spanish families with at least 3 cases of breast and/or ovarian cancer (at least 1 case diagnosed before age 50) in the same lineage were screened for germline mutations in the entire coding sequence and intron boundaries of the breast cancer susceptibility genes <em>BRCA1</em> and <em>BRCA2</em>. Overall, the prevalence of mutations was 43% in female breast/ovarian cancer families, 15% in female breast cancer families and 100% in male breast cancer families. Three recurrent mutations (185delAG, 589delCT and A1708E) explained 63% of <em>BRCA1</em>-related families. Early age at diagnosis of breast cancer, ovarian cancer, bilateral breast cancer, concomitant breast/ovarian cancer in a single patient and prostate cancer but not unilateral breast cancer were associated with <em>BRCA1</em> and <em>BRCA2</em> mutations. Male breast cancer was associated with <em>BRCA2</em> mutations. The presence of male breast cancer was the only cancer phenotype that distinguished <em>BRCA2-</em> from <em>BRCA1</em>-related families. We have developed a logistic regression model for predicting the probability of harbouring a mutation in either <em>BRCA1</em> or <em>BRCA2</em> as a function of the cancer phenotype present in the family. The predictive positive and negative values of this model were 77.4% and 79%, respectively (probability cutoff of 30%). The findings of our work may be a useful tool for increasing the cost-effectiveness of genetic testing in familial cancer clinics. &copy; 2001 Wiley-Liss, Inc.</p></div></div><div class="section" id="sec1-bdy-1"><div class="para"><p>Cancer of the breast is the most common malignancy among women in Western countries. In 5&ndash;10% of these patients, the disease can be attributed to an inherited predisposition.<a href="#bib1" rel="references:#bib1" class="referenceLink" title="Link to bibliographic citation" shape="rect">1</a> A linkage-based study estimated that the breast and ovarian cancer susceptibility genes <em>BRCA1</em> and <em>BRCA2</em> account, respectively, for 52% and 32% of all hereditary breast and/or ovarian cancer families with at least 4 breast cancer cases.<a href="#bib2" rel="references:#bib2 #bib3 #bib4" class="referenceLink" title="Link to bibliographic citations" shape="rect">2&ndash;4</a> Mutation-based studies indicated that defects in the 2 breast/ovarian cancer susceptibility genes account for a varying fraction of breast cancer families in different populations.<a href="#bib5" rel="references:#bib5" class="referenceLink" title="Link to bibliographic citation" shape="rect">5</a> The risk of breast and ovarian cancer associated with mutations in these 2 genes has been estimated,<a href="#bib4" rel="references:#bib4" class="referenceLink" title="Link to bibliographic citation" shape="rect">4</a> and other cancer types to which mutation carriers are predisposed have been identified.<a href="#bib6" rel="references:#bib6 #bib7 #bib8 #bib9" class="referenceLink" title="Link to bibliographic citations" shape="rect">6&ndash;9</a></p></div><div class="para"><p>Today, many families with a moderate number of breast and/or ovarian cancer cases seek genetic testing in familial cancer clinics. Unfortunately, current laboratory methods are costly and time-consuming due to the fact that <em>BRCA1</em> and <em>BRCA2</em> mutations are apparently randomly distributed over the large coding sequence of both genes.<a href="#bib10" rel="references:#bib10" class="referenceLink" title="Link to bibliographic citation" shape="rect">10</a> A negative result does not indicate the absence of genetic predisposition in the family because PCR-based protocols do not detect genomic rearrangements and allele-specific transcription defects. Moreover, there is also evidence of other as yet unknown predisposing genes.<a href="#bib4" rel="references:#bib4" class="referenceLink" title="Link to bibliographic citation" shape="rect">4</a> Management of these families does not defer either without testing or with a negative testing result. Ideally, one would prefer to target the available resources for DNA testing to individuals with the highest probability of being a gene carrier. It is, therefore, important to find the clinical factors that could predict the presence of <em>BRCA1</em> and <em>BRCA2</em> mutations. This is best done by characterising the complete spectrum of mutations in a sufficient number of phenotypically fully characterised families. Probabilistic models of this kind are limited and restricted either to <em>BRCA1</em> alone,<a href="#bib11" rel="references:#bib11" class="referenceLink" title="Link to bibliographic citation" shape="rect">11</a>, <a href="#bib12" rel="references:#bib12" class="referenceLink" title="Link to bibliographic citation" shape="rect">12</a> to the Ashkenazi Jewish population<a href="#bib13" rel="references:#bib13" class="referenceLink" title="Link to bibliographic citation" shape="rect">13</a> or to certain mutation mechanisms.<a href="#bib14" rel="references:#bib14" class="referenceLink" title="Link to bibliographic citation" shape="rect">14</a> Recently, a study involving both <em>BRCA1</em> and <em>BRCA2</em> genes in a series of Finish families with at least 3 cases of breast and/or ovarian cancer has been published.<a href="#bib15" rel="references:#bib15" class="referenceLink" title="Link to bibliographic citation" shape="rect">15</a> Although a direct comparison of these models is not possible due to different entry criteria, target populations, mutation screening protocols and clinical parameters analyzed, different predictive values for some clinical parameters such as bilateral breast cancer, breast and ovarian cancer in a single woman or unilateral breast cancer are suggested. It is conceivable that different probabilistic models must be developed for different target populations because the genetic background, environmental factors or specific prevalent <em>BRCA1</em> or <em>BRCA2</em> mutations may modify the outcome of the study.</p></div><div class="para"><p>The prevalence of <em>BRCA1</em> and <em>BRCA2</em> mutations among Spanish breast cancer families and their clinical features have not yet been thoroughly studied.<a href="#bib16" rel="references:#bib16" class="referenceLink" title="Link to bibliographic citation" shape="rect">16</a>, <a href="#bib17" rel="references:#bib17" class="referenceLink" title="Link to bibliographic citation" shape="rect">17</a> Here we report the study of <em>BRCA1</em> and <em>BRCA2</em> mutations in 102 Spanish families with at least 3 affected members, and we develop a logistic regression model predicting the probability of a family carrying a mutation as a function of the associated cancer phenotype.</p></div></div><div class="section" id="sec1-1"><div class="headingCont"><h3>MATERIAL AND METHODS</h3></div><ol class="jumpList"><li><a href="#leftBorder" shape="rect">Top of page</a></li><li><a href="#abstract" shape="rect">Abstract</a></li><li><a href="#sec1-1" shape="rect">MATERIAL AND METHODS</a></li><li><a href="#sec1-2" shape="rect">RESULTS</a></li><li><a href="#sec1-3" shape="rect">DISCUSSION</a></li><li><a href="#sec1-ack-1" shape="rect">Acknowledgements</a></li><li><a href="#wol-references" shape="rect">REFERENCES</a></li></ol><div class="section" id="sec2-1"><h4>Families</h4><div class="para"><p>The cohort studied consisted of 102 families with 3 or more first- or second-degree relatives affected with breast and/or ovarian cancer in the same lineage with at least 1 case diagnosed before age 50. The Molecular Oncology Laboratory at San Carlos Hospital (Madrid) and the Department of Human Genetics, National Center of Cancer (Madrid) contributed 48 and 46 families (indexed respectively as SC or CNIO throughout this work), while the Institute Portuguese of Oncology (Porto) contributed 8 (5 Spanish and 3 Portuguese) families (indexed as IPO throughout this work). Some of these families have been included in previous works.<a href="#bib16" rel="references:#bib16 #bib17 #bib18" class="referenceLink" title="Link to bibliographic citations" shape="rect">16&ndash;18</a> Pedigrees were constructed on the basis of an index case considered to have the highest probability of being a deleterious mutation carrier (generally a woman with early-onset breast or ovarian cancer), with her first- to third-degree relatives on both parental sides being taken into consideration. All information concerning the family history of cancers, ages at onset, either ages at death or current ages and other clinical parameters were obtained by personal interview of the index case and most relatives. The data were verified on the basis of medical and pathologic records for all selected patients. After appropriate written consent was obtained, a blood sample was collected from each individual who decided to participate in our study.</p></div><div class="para"><p>In the total set of 102 families, 62 families showed breast cancer patients with on average 3.8 &plusmn; 1.25 cases per family. In one family, only ovarian cancer was diagnosed (CNIO 102). Thirty-nine families did include both types of cancer and had on average 3.2 &plusmn; 1.88 and 1.7 &plusmn;1 cases of breast and ovarian cancer, respectively. The mean age at diagnosis of breast cancer was 48.9 &plusmn; 8.25. The mean age at diagnosis of ovarian cancer was 48.8 &plusmn; 8.5.</p></div></div><div class="section" id="sec2-2"><h4>Mutation analysis</h4><div class="para"><p>The complete coding sequence and exon-intron boundaries of <em>BRCA1</em> and <em>BRCA2</em> were analysed for germline mutations using a combination of SSCP and protein truncation tests in 46 CNIO families<a href="#bib17" rel="references:#bib17" class="referenceLink" title="Link to bibliographic citation" shape="rect">17</a> or a combination of DGGE<a href="#bib18" rel="references:#bib18" class="referenceLink" title="Link to bibliographic citation" shape="rect">18</a> and f-CSGE<a href="#bib19" rel="references:#bib19" class="referenceLink" title="Link to bibliographic citation" shape="rect">19</a> in 48 SC families and 8 IPO families. Sequencing was performed using an automated fluorescent-based cycle sequencer and Rhodamine Dye Terminator kit (Applied Biosystems, Foster City, CA). All protocols are available upon request.</p></div></div><div class="section" id="sec2-3"><h4>Statistical analysis</h4><div class="para"><p>SPSS 8.0 for Windows was used in all analysis. Association between specific familial cancer phenotypes and the presence of <em>BRCA1</em> or <em>BRCA2</em> germline mutations were studied by univariate and multivariate analysis. For univariate analysis, Mann-Whitney and Fisher's exact tests were used. Factors that were significant (<em>p</em> &lt; 0.01) were entered in multivariate analysis. Logistic regression with backward selection was used to calculate the logarithm of odds of carrying a pathogenic mutation as a linear function of significant variables from the univariate analysis.</p></div></div></div><div class="section" id="sec1-2"><div class="headingCont"><h3>RESULTS</h3></div><ol class="jumpList"><li><a href="#leftBorder" shape="rect">Top of page</a></li><li><a href="#abstract" shape="rect">Abstract</a></li><li><a href="#sec1-1" shape="rect">MATERIAL AND METHODS</a></li><li><a href="#sec1-2" shape="rect">RESULTS</a></li><li><a href="#sec1-3" shape="rect">DISCUSSION</a></li><li><a href="#sec1-ack-1" shape="rect">Acknowledgements</a></li><li><a href="#wol-references" shape="rect">REFERENCES</a></li></ol><div class="section" id="sec2-4"><h4>Prevalence of deleterious mutations</h4><div class="para"><p>We have screened the index cases of 102 breast and/or ovarian families for mutations in the breast/ovarian cancer susceptibility genes <em>BRCA1</em> and <em>BRCA2</em>. Prevalence of definite pathogenic mutations are shown in Table <a href="#tbl1" rel="references:#tbl1" class="tableLink" title="Link to table" shape="rect">I</a>. Overall, 31 families (30%) carrying deleterious mutations were detected. One family carried a <em>BRCA1</em> as well as a <em>BRCA2</em> mutation.</p></div><div linkid="" class="table" id="tbl1"><table class="topbotR"><caption><span class="tTitle"><span class="label">Table&nbsp;I.&nbsp;</span>Proportion of Spanish Families Carrying <em>BRCA1</em> and/or <em>BRCA2</em> Deleterious Mutations</span></caption><thead><tr class="rsep vBottom"><th class="hLeft" rowspan="1" colspan="1">Families</th><th class="hCenter" rowspan="1" colspan="1"><em>BRCA</em>-positive families</th><th class="hCenter" rowspan="1" colspan="1">Proportion (CI)<a href="#fn2" rel="references:#fn2" class="noteLink" title="Link to note" shape="rect">1</a></th><th class="hCenter" rowspan="1" colspan="1"><em>BRCA1</em>-positive families</th><th class="hCenter" rowspan="1" colspan="1">Proportion (CI)</th><th class="hCenter" rowspan="1" colspan="1"><em>BRCA2</em>- positive families</th><th class="hCenter" rowspan="1" colspan="1">Proportion (CI)</th><th class="hCenter" rowspan="1" colspan="1"><em>BRCA1/2</em>-positive families<a href="#fn3" rel="references:#fn3" class="noteLink" title="Link to note" shape="rect">2</a></th></tr></thead><tfoot><tr><td colspan="8" rowspan="1"><div class="noteGroup"><ul id="footnotes" class="noteGroup custom"><li id="fn2"><span class="bullet">1</span><div class="text"><p>CI, 95% confidence interval.</p></div></li><li id="fn3"><span class="bullet">2</span><div class="text"><p>Families carrying deleterious mutations in both genes.</p></div></li></ul></div></td></tr></tfoot><tbody><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">Femalebreast/ovarian cancer</td><td class="hChar" rowspan="1" colspan="1">16/37</td><td class="hChar" rowspan="1" colspan="1">0.43 (0.25&ndash;0.56)</td><td class="hChar" rowspan="1" colspan="1">11/37</td><td class="hChar" rowspan="1" colspan="1">0.30 (0.17&ndash;0.53)</td><td class="hChar" rowspan="1" colspan="1">5/37</td><td class="hChar" rowspan="1" colspan="1">0.13 (0.04&ndash;0.31)</td><td class="hChar" rowspan="1" colspan="1">0/37</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">Female breast cancer</td><td class="hChar" rowspan="1" colspan="1">9/59</td><td class="hChar" rowspan="1" colspan="1">0.15 (0.07&ndash;0.26)</td><td class="hChar" rowspan="1" colspan="1">6/59</td><td class="hChar" rowspan="1" colspan="1">0.10 (0.04&ndash;0.20)</td><td class="hChar" rowspan="1" colspan="1">2/59</td><td class="hChar" rowspan="1" colspan="1">0.03 (0&ndash;0.11)</td><td class="hChar" rowspan="1" colspan="1">1/59</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">Male breast cancer</td><td class="hChar" rowspan="1" colspan="1">5/5</td><td class="hChar" rowspan="1" colspan="1">1.0 (0.48&ndash;1.0)</td><td class="hChar" rowspan="1" colspan="1">0/5</td><td class="hChar" rowspan="1" colspan="1">0 (0&ndash;0.52)</td><td class="hChar" rowspan="1" colspan="1">5/5</td><td class="hChar" rowspan="1" colspan="1">1.0 (0.48&ndash;1)</td><td class="hChar" rowspan="1" colspan="1">0/5</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">Ovarian cancer</td><td class="hChar" rowspan="1" colspan="1">1/1</td><td class="hChar" rowspan="1" colspan="1">1.0</td><td class="hChar" rowspan="1" colspan="1">1/1</td><td class="hChar" rowspan="1" colspan="1">1.0</td><td class="hChar" rowspan="1" colspan="1">0/0</td><td class="hChar" rowspan="1" colspan="1">0 (0&ndash;0.60)</td><td class="hChar" rowspan="1" colspan="1">0/1</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">Total</td><td class="hChar" rowspan="1" colspan="1">31/102</td><td class="hChar" rowspan="1" colspan="1">0.30 (0.21&ndash;0.39)</td><td class="hChar" rowspan="1" colspan="1">18/102</td><td class="hChar" rowspan="1" colspan="1">0.18 (0.10&ndash;0.25)</td><td class="hChar" rowspan="1" colspan="1">12/102</td><td class="hChar" rowspan="1" colspan="1">0.12 (0.06&ndash;0.18)</td><td class="hChar" rowspan="1" colspan="1">1/102</td></tr></tbody></table></div><div class="para"><p>The prevalence of <em>BRCA1</em> mutations was approximately 3 times the prevalence of <em>BRCA2</em> mutations both in female breast/ovarian (30% <em>vs.</em> 13%; <em>p</em> &lt; 0.05) and female site-specific breast cancer families (10% <em>vs.</em> 3%; <em>p</em> &lt; 0.01).</p></div><div class="para"><p>Our cohort included 5 families with cases of male breast cancer (3 breast cancer families and 2 breast/ovarian cancer families). All 5 families (100%) carried a <em>BRCA2</em> mutation. There was only 1 ovarian cancer family in our cohort (5 affected members). This family carried a <em>BRCA1</em> mutation.</p></div><div class="para"><p>The lowest rate of mutation prevalence was found among the group of families with 3 female breast cancer cases. In this group, only 1 family of 24 (4%; 95% CI 13&ndash;24.9%) carried a <em>BRCA1</em> mutation (CNIO 170). Interestingly, the average age at diagnosis of breast cancer for this family was 31 years, 20 years lower than the average age at diagnosis of breast cancer for this group of families (50 years).</p></div></div><div class="section" id="sec2-5"><h4>Mutation spectrum</h4><div class="para"><p>We found 10 <em>BRCA1</em> frame-shifting mutations (52.6%), 5 missense mutations (26.3%, all of them clustered in the C-terminal transcriptional domain) and 4 splicing alterations. We did not find any nonsense mutation (Table <a href="#tbl2" rel="references:#tbl2" class="tableLink" title="Link to table" shape="rect">II</a>). Ten mutations mapped in the 5&prime; end of the gene and 9 mapped in the 3&prime; end. It is interesting to note that no single mutation mapped in the central exon 11, which encompasses 60% of the <em>BRCA1</em> coding sequence and a similar proportion of described mutations.<a href="#bib10" rel="references:#bib10" class="referenceLink" title="Link to bibliographic citation" shape="rect">10</a> We identified 3 recurrent mutations (185delAG in 5 families, 589delCT in 3 families and A1708E in 4 families), which explained 12 <em>BRCA1</em>-related families (63%; 95% CI 36&ndash;81%). These 3 recurrent mutations have been described previously in other populations.<a href="#bib10" rel="references:#bib10" class="referenceLink" title="Link to bibliographic citation" shape="rect">10</a> The <em>BRCA1</em> mutation 185delAG is associated with the same <em>BRCA1</em> haplotype first described in Ashkenazi Jews.<a href="#bib16" rel="references:#bib16" class="referenceLink" title="Link to bibliographic citation" shape="rect">16</a>, <a href="#bib20" rel="references:#bib20" class="referenceLink" title="Link to bibliographic citation" shape="rect">20</a> A1708E is one of the very few <em>BRCA1</em> missense mutations known to have a pathogenic role.<a href="#bib21" rel="references:#bib21" class="referenceLink" title="Link to bibliographic citation" shape="rect">21</a>, <a href="#bib22" rel="references:#bib22" class="referenceLink" title="Link to bibliographic citation" shape="rect">22</a> G1706E was found in 2 affected sisters from the same family, but it was not detected in 2 healthy relatives and in 200 control chromosomes. This alteration would be expected to be significant, since it results in the substitution of a small hydrophobic amino acid by a hydrophilic-charged amino acid, and it is localised in the C-terminal transcriptional domain.<a href="#bib17" rel="references:#bib17" class="referenceLink" title="Link to bibliographic citation" shape="rect">17</a>, <a href="#bib21" rel="references:#bib21" class="referenceLink" title="Link to bibliographic citation" shape="rect">21</a> For these reasons, although the status of the G1706E variant is still uncertain, we have considered this mutation to have a high probability of being associated with the cancer in the family.</p></div><div linkid="" class="table" id="tbl2"><table class="topbotR"><caption><span class="tTitle"><span class="label">Table&nbsp;II.&nbsp;</span><em>BRCA1</em> Mutations and Associated Phenotype in Spanish Breast/Ovarian Cancer Families</span></caption><thead><tr class="rsep vBottom"><th class="hLeft" rowspan="1" colspan="1">Family code</th><th class="hCenter" rowspan="1" colspan="1">Family history of cancer<a href="#fn4" rel="references:#fn4" class="noteLink" title="Link to note" shape="rect">1</a></th><th class="hCenter" rowspan="1" colspan="1">Mean age at breast cancer diagnosis</th><th class="hCenter" rowspan="1" colspan="1">Mean age at ovarian cancer diagnosis</th><th class="hCenter" rowspan="1" colspan="1"><em>BRCA1</em> mutation</th><th class="hCenter" rowspan="1" colspan="1">Exon</th><th class="hCenter" rowspan="1" colspan="1">Codon</th><th class="hCenter" rowspan="1" colspan="1">Described in other populations<a href="#fn5" rel="references:#fn5" class="noteLink" title="Link to note" shape="rect">2</a></th></tr></thead><tfoot><tr><td colspan="8" rowspan="1"><div class="noteGroup"><ul id="footnotes" class="noteGroup custom"><li id="fn4"><span class="bullet">1</span><div class="text"><p>BC, breast cancer (bilateral breast cancer) cases; OC, ovarian cancer cases; CBO, breast and ovarian cancer in a single woman; MBC, male breast cancer cases; PC, prostate cancer cases; C, other cancer cases.</p></div></li><li id="fn5"><span class="bullet">2</span><div class="text"><p>BIC database, March 2001.</p></div></li></ul></div></td></tr></tfoot><tbody><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 121</td><td class="hLeft" rowspan="1" colspan="1">3(1)BC+2OC+1PC+3C</td><td class="hCenter" rowspan="1" colspan="1">46</td><td class="hCenter" rowspan="1" colspan="1">47</td><td class="hLeft" rowspan="1" colspan="1">185 delAG</td><td class="hChar" rowspan="1" colspan="1">2</td><td class="hLeft" rowspan="1" colspan="1">Stop 39</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 38</td><td class="hLeft" rowspan="1" colspan="1">2BC+1CBO</td><td class="hCenter" rowspan="1" colspan="1">54</td><td class="hCenter" rowspan="1" colspan="1">55</td><td class="hLeft" rowspan="1" colspan="1">185 delAG</td><td class="hChar" rowspan="1" colspan="1">2</td><td class="hLeft" rowspan="1" colspan="1">Stop 39</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 8</td><td class="hLeft" rowspan="1" colspan="1">1BC+1OC+1CBO</td><td class="hCenter" rowspan="1" colspan="1">35</td><td class="hLeft" rowspan="1" colspan="1">185 delAG</td><td class="hChar" rowspan="1" colspan="1">2</td><td class="hLeft" rowspan="1" colspan="1">Stop 39</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 102</td><td class="hLeft" rowspan="1" colspan="1">5OC</td><td class="hLeft" rowspan="1" colspan="1">185 delAG</td><td class="hChar" rowspan="1" colspan="1">2</td><td class="hLeft" rowspan="1" colspan="1">Stop 39</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 170</td><td class="hLeft" rowspan="1" colspan="1">3BC</td><td class="hCenter" rowspan="1" colspan="1">31</td><td class="hLeft" rowspan="1" colspan="1">185 delAG</td><td class="hChar" rowspan="1" colspan="1">2</td><td class="hLeft" rowspan="1" colspan="1">Stop 39</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 73</td><td class="hLeft" rowspan="1" colspan="1">2OC+2CBO+</td><td class="hCenter" rowspan="1" colspan="1">44</td><td class="hCenter" rowspan="1" colspan="1">45</td><td class="hLeft" rowspan="1" colspan="1">236 delTG</td><td class="hChar" rowspan="1" colspan="1">3</td><td class="hLeft" rowspan="1" colspan="1">Stop 39</td><td class="hLeft" rowspan="1" colspan="1">No</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 3</td><td class="hLeft" rowspan="1" colspan="1">3(1)BC+1OC+1CBO</td><td class="hCenter" rowspan="1" colspan="1">59,5</td><td class="hCenter" rowspan="1" colspan="1">62</td><td class="hLeft" rowspan="1" colspan="1">589 delCT</td><td class="hChar" rowspan="1" colspan="1">8</td><td class="hLeft" rowspan="1" colspan="1">Stop 157</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 42</td><td class="hLeft" rowspan="1" colspan="1">2(2)BC+1OC+2CBO+1PC</td><td class="hCenter" rowspan="1" colspan="1">38,5</td><td class="hCenter" rowspan="1" colspan="1">45</td><td class="hLeft" rowspan="1" colspan="1">589 delCT</td><td class="hChar" rowspan="1" colspan="1">8</td><td class="hLeft" rowspan="1" colspan="1">Stop 157</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 18</td><td class="hLeft" rowspan="1" colspan="1">2(2)BC</td><td class="hCenter" rowspan="1" colspan="1">39</td><td class="hLeft" rowspan="1" colspan="1">589 del CT</td><td class="hChar" rowspan="1" colspan="1">8</td><td class="hLeft" rowspan="1" colspan="1">Stop 157</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 5</td><td class="hLeft" rowspan="1" colspan="1">3BC+1OC</td><td class="hCenter" rowspan="1" colspan="1">36</td><td class="hCenter" rowspan="1" colspan="1">36</td><td class="hLeft" rowspan="1" colspan="1">4229insATCT</td><td class="hChar" rowspan="1" colspan="1">12</td><td class="hLeft" rowspan="1" colspan="1">Stop 1374</td><td class="hLeft" rowspan="1" colspan="1">No</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 61</td><td class="hLeft" rowspan="1" colspan="1">4BC+2OC+1PC+3C</td><td class="hCenter" rowspan="1" colspan="1">49</td><td class="hCenter" rowspan="1" colspan="1">40</td><td class="hLeft" rowspan="1" colspan="1">5242 C/T</td><td class="hChar" rowspan="1" colspan="1">18</td><td class="hLeft" rowspan="1" colspan="1">A 1708 E</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 81</td><td class="hLeft" rowspan="1" colspan="1">4BC+3C</td><td class="hCenter" rowspan="1" colspan="1">42</td><td class="hLeft" rowspan="1" colspan="1">5242 C/T</td><td class="hChar" rowspan="1" colspan="1">18</td><td class="hLeft" rowspan="1" colspan="1">A 1708 E</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 7</td><td class="hLeft" rowspan="1" colspan="1">5(2)BC</td><td class="hCenter" rowspan="1" colspan="1">51</td><td class="hLeft" rowspan="1" colspan="1">5242 C/T</td><td class="hChar" rowspan="1" colspan="1">18</td><td class="hLeft" rowspan="1" colspan="1">A 1708 E</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 121</td><td class="hLeft" rowspan="1" colspan="1">4BC+4C</td><td class="hCenter" rowspan="1" colspan="1">43,25</td><td class="hLeft" rowspan="1" colspan="1">5242 C/T</td><td class="hChar" rowspan="1" colspan="1">18</td><td class="hLeft" rowspan="1" colspan="1">A 1708 E</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 72</td><td class="hLeft" rowspan="1" colspan="1">3(1)BC</td><td class="hCenter" rowspan="1" colspan="1">34</td><td class="hCenter" rowspan="1" colspan="1">45</td><td class="hLeft" rowspan="1" colspan="1">5236 G/A</td><td class="hChar" rowspan="1" colspan="1">18</td><td class="hLeft" rowspan="1" colspan="1">G 1706 E</td><td class="hLeft" rowspan="1" colspan="1">No</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 36</td><td class="hLeft" rowspan="1" colspan="1">6BC</td><td class="hCenter" rowspan="1" colspan="1">38</td><td class="hLeft" rowspan="1" colspan="1">5272-1G/A</td><td class="hChar" rowspan="1" colspan="1">IVS 18</td><td class="hLeft" rowspan="1" colspan="1">Splicing</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 4</td><td class="hLeft" rowspan="1" colspan="1">1BC+3OC+1PC</td><td class="hCenter" rowspan="1" colspan="1">55</td><td class="hCenter" rowspan="1" colspan="1">53</td><td class="hLeft" rowspan="1" colspan="1">5272-1G/C</td><td class="hChar" rowspan="1" colspan="1">IVS 18</td><td class="hLeft" rowspan="1" colspan="1">Splicing</td><td class="hLeft" rowspan="1" colspan="1">No</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 134</td><td class="hLeft" rowspan="1" colspan="1">2(1)BC</td><td class="hCenter" rowspan="1" colspan="1">45</td><td class="hLeft" rowspan="1" colspan="1">5396+1G/C</td><td class="hChar" rowspan="1" colspan="1">IVS 20</td><td class="hLeft" rowspan="1" colspan="1">Splicing</td><td class="hLeft" rowspan="1" colspan="1">No</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 2</td><td class="hLeft" rowspan="1" colspan="1">4(1)BC</td><td class="hCenter" rowspan="1" colspan="1">48,4</td><td class="hCenter" rowspan="1" colspan="1">47</td><td class="hLeft" rowspan="1" colspan="1">5397-1G/C</td><td class="hChar" rowspan="1" colspan="1">IVS 20</td><td class="hLeft" rowspan="1" colspan="1">Splicing</td><td class="hLeft" rowspan="1" colspan="1">No</td></tr></tbody></table></div><div linkid="" class="table" id="tbl3"><table class="topbotR"><caption><span class="tTitle"><span class="label">Table&nbsp;III.&nbsp;</span><em>BRCA2</em> Mutations and Associated Phenotype in Spanish Breast/Ovarian Cancer Families</span></caption><thead><tr class="rsep vBottom"><th class="hLeft" rowspan="1" colspan="1">Family code</th><th class="hCenter" rowspan="1" colspan="1">Family history of cancer<a href="#fn6" rel="references:#fn6" class="noteLink" title="Link to note" shape="rect">1</a></th><th class="hCenter" rowspan="1" colspan="1">Mean age at breast cancer diagnosis</th><th class="hCenter" rowspan="1" colspan="1">Mean age at ovarian cancer diagnosis</th><th class="hCenter" rowspan="1" colspan="1"><em>BRCA2</em> mutation</th><th class="hCenter" rowspan="1" colspan="1">Exon</th><th class="hCenter" rowspan="1" colspan="1">Effect</th><th class="hCenter" rowspan="1" colspan="1">Described in other populations<a href="#fn7" rel="references:#fn7" class="noteLink" title="Link to note" shape="rect">2</a></th></tr></thead><tfoot><tr><td colspan="8" rowspan="1"><div class="noteGroup"><ul id="footnotes" class="noteGroup custom"><li id="fn6"><span class="bullet">1</span><div class="text"><p>BC(bi), breast cancer (bilateral breast cancer) cases; OC, ovarian cancer cases; CBO, breast and ovarian cancer in a single woman; MBC, male breast cancer cases; PC, prostate cancer cases.</p></div></li><li id="fn7"><span class="bullet">2</span><div class="text"><p>BIC database, March 2001.</p></div></li><li id="fn8"><span class="bullet">3</span><div class="text"><p>8234del GGCTATAAAAAAGATAATGGAAA.</p></div></li></ul></div></td></tr></tfoot><tbody><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">PO 3/00</td><td class="hLeft" rowspan="1" colspan="1">2BC+1OC</td><td class="hChar" rowspan="1" colspan="1">53.5</td><td class="hCenter" rowspan="1" colspan="1">43</td><td class="hLeft" rowspan="1" colspan="1">1380 A/T</td><td class="hCenter" rowspan="1" colspan="1">10</td><td class="hLeft" rowspan="1" colspan="1">K 385 stop</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">PO 19/99</td><td class="hLeft" rowspan="1" colspan="1">4(1)BC</td><td class="hChar" rowspan="1" colspan="1">32.5</td><td class="hLeft" rowspan="1" colspan="1">2042 delA</td><td class="hCenter" rowspan="1" colspan="1">10</td><td class="hLeft" rowspan="1" colspan="1">Stop 613</td><td class="hLeft" rowspan="1" colspan="1">No</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 21</td><td class="hLeft" rowspan="1" colspan="1">4(2)BC+2OC+1C</td><td class="hChar" rowspan="1" colspan="1">40</td><td class="hCenter" rowspan="1" colspan="1">51</td><td class="hLeft" rowspan="1" colspan="1">3034 delAAAC</td><td class="hCenter" rowspan="1" colspan="1">11</td><td class="hLeft" rowspan="1" colspan="1">Stop 958</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 59</td><td class="hLeft" rowspan="1" colspan="1">4BC+2OC+1PC</td><td class="hChar" rowspan="1" colspan="1">37.5</td><td class="hLeft" rowspan="1" colspan="1">3034 delAAAC</td><td class="hCenter" rowspan="1" colspan="1">11</td><td class="hLeft" rowspan="1" colspan="1">Stop 958</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 110</td><td class="hLeft" rowspan="1" colspan="1">3BC+1MBC+3C</td><td class="hChar" rowspan="1" colspan="1">43.3</td><td class="hLeft" rowspan="1" colspan="1">3034 delAAAC</td><td class="hCenter" rowspan="1" colspan="1">11</td><td class="hLeft" rowspan="1" colspan="1">Stop 958</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 126</td><td class="hLeft" rowspan="1" colspan="1">5(1)BC+1OC</td><td class="hChar" rowspan="1" colspan="1">53.8</td><td class="hCenter" rowspan="1" colspan="1">61</td><td class="hLeft" rowspan="1" colspan="1">3492 insT</td><td class="hCenter" rowspan="1" colspan="1">11</td><td class="hLeft" rowspan="1" colspan="1">Stop 1098</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 16</td><td class="hLeft" rowspan="1" colspan="1">2(1)BC+1MBC+1PC</td><td class="hChar" rowspan="1" colspan="1">48.5</td><td class="hLeft" rowspan="1" colspan="1">5804 del4</td><td class="hCenter" rowspan="1" colspan="1">11</td><td class="hLeft" rowspan="1" colspan="1">Stop 1861</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 121</td><td class="hLeft" rowspan="1" colspan="1">4BC+2PC</td><td class="hChar" rowspan="1" colspan="1">43.25</td><td class="hLeft" rowspan="1" colspan="1">6503 delTT</td><td class="hCenter" rowspan="1" colspan="1">11</td><td class="hLeft" rowspan="1" colspan="1">Stop 2098</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 24</td><td class="hLeft" rowspan="1" colspan="1">1BC+3OC+1MBC</td><td class="hChar" rowspan="1" colspan="1">49</td><td class="hLeft" rowspan="1" colspan="1">7336 delAA</td><td class="hCenter" rowspan="1" colspan="1">14</td><td class="hLeft" rowspan="1" colspan="1">Stop 2390</td><td class="hLeft" rowspan="1" colspan="1">No</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 8</td><td class="hLeft" rowspan="1" colspan="1">6(1)BC</td><td class="hChar" rowspan="1" colspan="1">66.75</td><td class="hLeft" rowspan="1" colspan="1">8234 del 23<a href="#fn8" rel="references:#fn8" class="noteLink" title="Link to note" shape="rect">3</a></td><td class="hCenter" rowspan="1" colspan="1">18</td><td class="hLeft" rowspan="1" colspan="1">Stop 2673</td><td class="hLeft" rowspan="1" colspan="1">No</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 22</td><td class="hLeft" rowspan="1" colspan="1">4(3)BC+3MBC</td><td class="hChar" rowspan="1" colspan="1">42</td><td class="hLeft" rowspan="1" colspan="1">9254 del5</td><td class="hCenter" rowspan="1" colspan="1">23</td><td class="hLeft" rowspan="1" colspan="1">Stop 3015</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">SC 106</td><td class="hLeft" rowspan="1" colspan="1">4(2)BC+1OC+1CBO+3C</td><td class="hChar" rowspan="1" colspan="1">48.3</td><td class="hCenter" rowspan="1" colspan="1">40</td><td class="hLeft" rowspan="1" colspan="1">9514 G&gt;A</td><td class="hCenter" rowspan="1" colspan="1">25</td><td class="hLeft" rowspan="1" colspan="1">E 3096 stop</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">CNIO 45</td><td class="hLeft" rowspan="1" colspan="1">11BC+1CBO+1MBC</td><td class="hChar" rowspan="1" colspan="1">40</td><td class="hLeft" rowspan="1" colspan="1">9538 delAA</td><td class="hCenter" rowspan="1" colspan="1">25</td><td class="hLeft" rowspan="1" colspan="1">Stop 3109</td><td class="hLeft" rowspan="1" colspan="1">Yes</td></tr></tbody></table></div><div class="para"><p>We identified 11 <em>BRCA2</em> frame-shifting mutations (84.6%) and 2 nonsense mutations (15.4%). We did not identify mutations affecting splice sites (Table <a href="#tbl3" rel="references:#tbl3" class="tableLink" title="Link to table" shape="rect">III</a>). Most <em>BRCA2</em> mutations (70%) mapped in exons 10 and 11, which encompass 60% of the coding sequence. Only 1 <em>BRCA2</em> recurrent mutation (3034 delAAAC), which explains 3 families (23%), was identified. This recurrent mutation has been previously described in other populations.<a href="#bib10" rel="references:#bib10" class="referenceLink" title="Link to bibliographic citation" shape="rect">10</a></p></div></div><div class="section" id="sec2-6"><h4>Cancer phenotype differences between mutated and nonmutated families</h4><div class="para"><p>We investigated whether some familial traits are differentially expressed in <em>BRCA1/2</em> mutated <em>vs.</em> nonmutated families. For this purpose we evaluated the presence in the family of the following cancer phenotypes: at least 5 female unilateral breast cancers, only female breast cancers, presence of bilateral breast cancers, ovarian cancers, breast and ovarian cancers in a single woman, prostate cancer and any other cancer. Finally, we also considered the mean age at diagnosis of breast and ovarian cancer. Results are shown in Table <a href="#tbl4" rel="references:#tbl4" class="tableLink" title="Link to table" shape="rect">IV</a>.</p></div><div linkid="" class="table" id="tbl4"><table class="topbotR"><caption><span class="tTitle"><span class="label">Table&nbsp;IV.&nbsp;</span>Proportion of <em>BRCA1/2</em>-Mutated and <em>BRCA1/2</em>-Nonmutated Spanish Breast/Ovarian Families Showing the Cancer Phenotype Indicated</span></caption><thead><tr class="rsep vBottom"><th class="hLeft" rowspan="1" colspan="1">Family cancer phenotype<a href="#fn9" rel="references:#fn9" class="noteLink" title="Link to note" shape="rect">1</a></th><th class="hCenter" rowspan="1" colspan="1"><em>BRCA1/2</em>-positive families</th><th class="hCenter" rowspan="1" colspan="1"><em>BRCA1/2</em>-negative families</th><th class="hCenter" rowspan="1" colspan="1">&nbsp;</th></tr></thead><tfoot><tr><td colspan="4" rowspan="1"><div class="noteGroup"><ul id="footnotes" class="noteGroup custom"><li id="fn9"><span class="bullet">1</span><div class="text"><p>BC, breast cancer; biBC, bilateral breast cancer; OC, ovarian cancer; CBO, breast and ovarian cancer in a single woman; MBC, male breast cancer; PC, prostate cancer; BCdx, breast cancer diagnosis; OCdx, ovarian cancer diagnosis. 95% CI or &plusmn; SD are indicated.</p></div></li></ul></div></td></tr></tfoot><tbody><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">At least 5 BC</td><td class="hCenter" rowspan="1" colspan="1">0.10 (0.02&ndash;0.26)</td><td class="hCenter" rowspan="1" colspan="1">0.10 (0.04&ndash;0.19)</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">Only BC</td><td class="hCenter" rowspan="1" colspan="1">0.10 (0.02&ndash;0.26)</td><td class="hCenter" rowspan="1" colspan="1">0.51 (0.39&ndash;0.64)</td><td class="hCenter" rowspan="1" colspan="1"><em>p</em> &lt; 0.01</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">At least 1 biBC</td><td class="hCenter" rowspan="1" colspan="1">0.48 (0.31&ndash;0.69)</td><td class="hCenter" rowspan="1" colspan="1">0.25 (0.16&ndash;0.37)</td><td class="hCenter" rowspan="1" colspan="1"><em>p</em> &lt; 0.05</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">At least 1 OC</td><td class="hCenter" rowspan="1" colspan="1">0.50 (0.34&ndash;0.72)</td><td class="hCenter" rowspan="1" colspan="1">0.24 (0.15&ndash;0.36)</td><td class="hCenter" rowspan="1" colspan="1"><em>p</em> &lt; 0.01</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">At least 1 CBO</td><td class="hCenter" rowspan="1" colspan="1">0.25 (0.12&ndash;0.46)</td><td class="hCenter" rowspan="1" colspan="1">0.07 (0.02&ndash;0.16)</td><td class="hCenter" rowspan="1" colspan="1"><em>p</em> &lt; 0.05</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">At least 1 PC</td><td class="hCenter" rowspan="1" colspan="1">0.23 (0.10&ndash;0.42)</td><td class="hCenter" rowspan="1" colspan="1">0.06 (0.05&ndash;0.14)</td><td class="hCenter" rowspan="1" colspan="1"><em>p</em> &lt; 0.05</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">At least 1 other cancer type</td><td class="hCenter" rowspan="1" colspan="1">0.39 (0.23&ndash;0.59)</td><td class="hCenter" rowspan="1" colspan="1">0.60 (0.48&ndash;0.71)</td><td class="hCenter" rowspan="1" colspan="1"><em>p</em> &lt; 0.05</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">BCdx mean age</td><td class="hCenter" rowspan="1" colspan="1">45.0 &plusmn; 8.4</td><td class="hCenter" rowspan="1" colspan="1">51 &plusmn; 7.7</td><td class="hCenter" rowspan="1" colspan="1"><em>p</em> &lt; 0.01</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">OCdx mean age</td><td class="hCenter" rowspan="1" colspan="1">48.8 &plusmn; 7.3</td><td class="hCenter" rowspan="1" colspan="1">48.9 &plusmn; 11</td></tr></tbody></table></div><div class="para"><p>Families with bilateral breast cancers, ovarian cancers, breast and ovarian cancers in a single woman and prostate cancers were overrepresented in <em>BRCA1/2</em>-mutated families. By contrast, female unilateral breast cancer families were 5 times more frequent in the nonmutated group of families. It is interesting that the presence of cancer types other than breast, ovarian and prostate were 2 times more frequent in the nonmutated group of families. The median age at diagnosis of breast cancer was 6 years younger in <em>BRCA1/2</em>-mutated <em>vs.</em> nonmutated families. All these differences were statistically significant. On the other hand, the mean age at diagnosis of ovarian cancer and the number of families with at least 5 female breast cancers were identical in both mutated and nonmutated families.</p></div><div class="para"><p>We also tested whether these cancer phenotypes were differentially expressed in <em>BRCA1- vs. BRCA2</em>-mutated families (data not shown). Families with breast and ovarian cancer in a single woman were overrepresented (31.6% <em>vs.</em> 15.4%) in <em>BRCA1</em>-mutated families, although the difference was not statistically significant. Interestingly, families with at least 1 ovarian cancer were equally represented in both groups (57% <em>vs.</em> 54%).</p></div></div><div class="section" id="sec2-7"><h4>Predicting the probability of finding a mutation in the Spanish population</h4><div class="para"><p>On the basis of these clinical associations, we developed a logistic regression model to predict the probability of detecting a mutation in <em>BRCA1</em> or <em>BRCA2</em> as a function of cancer phenotype. In univariate analysis, bilateral breast cancer (<em>p</em> = 0.002), ovarian cancer (<em>p</em> = 0.005), breast and ovarian cancer in a single woman (<em>p</em> = 0.004), male breast cancer (<em>p</em> = 0.008), prostate cancer (<em>p</em> = 0.014) and mean age at diagnosis of breast cancer in the family (<em>p</em> = 0.009) were associated with <em>BRCA1/2</em> mutations. Unilateral female breast cancer was not significantly associated (<em>p</em> = 0.186). Variables that were significant at the <em>p</em> &lt; 0.01 level were entered into the multivariable analysis. The predictor variables were tested as ordinal/continuous and categorical variables in several different models. The best-fitting model was obtained by defining a new categorical variable that includes bilateral breast cancer, breast and ovarian cancer in a single woman and male breast cancer. Table <a href="#tbl5" rel="references:#tbl5" class="tableLink" title="Link to table" shape="rect">V</a> shows univariate and logistic regression analysis for the final model. The equation that describes the logistic regression function can be written as follows: </p><div class="equation" id="di-ueqn-1"><ul><li><img alt="equation image" src="http://onlinelibrary.wiley.com/store/10.1002/ijc.1627/asset/equation/nueq001.gif?v=1&amp;t=hlba7b5z&amp;s=787e396481a2f53da5bfb3846c10b603e07143fb" /></li></ul></div><p> In this formula, 2.26 is a constant; V<sub>1</sub> is the number of ovarian cancer cases in the family; V<sub>2</sub> = 1 when there is only 1 case of bilateral breast cancer, breast and ovarian cancer in a single woman or male breast cancer and V<sub>2</sub> = 0 in any other case; V<sub>3</sub> = 1 when there are at least 2 cases of bilateral breast cancer plus breast and ovarian cancer in a single woman plus male breast cancer and 0 when there are not; V<sub>4</sub> is the mean age at diagnosis of breast cancer. As an example, for family SC 3, which includes 1 ovarian cancer, 1 bilateral breast cancer, 1 breast and ovarian cancer in a single woman and a mean age at diagnosis of breast cancer of 59.5 years, the value of the variables would be V<sub>1</sub> = 1, V<sub>2</sub> = 0, V<sub>3</sub> = 1, V<sub>4</sub> = 59.5 and the probability of detecting a deleterious mutation in either <em>BRCA1</em> or <em>BRCA2</em> according to the model would be <em>p</em> = 0.54 (or 54%).</p></div><div linkid="" class="table" id="tbl5"><table class="topbotR"><caption><span class="tTitle"><span class="label">Table&nbsp;V.&nbsp;</span>Univariate and Logistic Regression Analysis</span></caption><thead><tr class="rsep vBottom"><th class="hLeft" rowspan="1" colspan="1">Family cancer phenotype</th><th class="hCenter" rowspan="1" colspan="1">Odds ratio univariate (95% CI)</th><th class="hCenter" rowspan="1" colspan="1">Adjusted odds ratio (95% CI)</th><th class="hCenter" rowspan="1" colspan="1">&nbsp;</th></tr></thead><tfoot><tr><td colspan="4" rowspan="1"><div class="noteGroup"><ol id="footnotes" class="noteGroup custom"><li id="note-p-28"><span class="bullet"><sup><i></i></sup></span><div class="text"><p><sup>1</sup>BC, breast cancer; biBC, bilateral breast cancer; OC, ovarian cancer; CBO, breast and ovarian cancer in a single woman; MBC, male breast cancer.</p></div></li></ol></div></td></tr></tfoot><tbody><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">Number of OC</td><td class="hChar" rowspan="1" colspan="1">2.00 (1.3&ndash;3.09)</td><td class="hChar" rowspan="1" colspan="1">1.82 (1.10&ndash;3.01)</td><td class="hCenter" rowspan="1" colspan="1"><em>p</em> = 0.020</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">One case of biBC, MBC or CBO</td><td class="hChar" rowspan="1" colspan="1">2.11 (0.75&ndash;5.89)</td><td class="hChar" rowspan="1" colspan="1">2.89 (0.92&ndash;9.05)</td><td class="hCenter" rowspan="1" colspan="1"><em>p</em> = 0.068</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">At least 2 cases of biBC, MBC or CBO (any combination)</td><td class="hChar" rowspan="1" colspan="1">16.33 (3.89&ndash;68.54)</td><td class="hChar" rowspan="1" colspan="1">13.93 (2.90&ndash;66.76)</td><td class="hCenter" rowspan="1" colspan="1"><em>p</em> = 0.001</td></tr><tr class="none vTop"><td class="hLeft" rowspan="1" colspan="1">BCdx mean age</td><td class="hChar" rowspan="1" colspan="1">0.91 (0.85&ndash;0.97)</td><td class="hChar" rowspan="1" colspan="1">0.91 (0.85&ndash;0.98)</td><td class="hCenter" rowspan="1" colspan="1"><em>p</em> = 0.009</td></tr></tbody></table></div><div class="para"><p>In our cohort, the mean probability of detecting a mutation according to this model was 54% for mutation-positive families and 19% for mutation-negative families.</p></div><div class="para"><p>Figure <a href="#fig1" rel="references:#fig1" class="figureLink" title="Link to figure" shape="rect">1</a> represents the positive and negative predictive values of our model as a function of different probability cutoff values. For a probability cutoff of 30%, the positive and negative predictive values of our model were 77.4% and 79%, respectively. Thus, for a cutoff of 30%, 62 of our 102 families (6 <em>BRCA1/2</em>-mutated and 56 nonmutated families) would not be referred for genetic testing, while only 40 families (25 <em>BRCA1/2</em>-mutated and 15 <em>BRCA1/2</em>-nonmutated families) would be, clearly increasing the cost effectiveness of the screening protocol.</p></div><div id="fig1" class="figure"><a class="figZoom" title="Link to full-size figure" href="http://onlinelibrary.wiley.com/store/10.1002/ijc.1627/asset/image_n/nfig001.gif?v=1&amp;t=hlba7b62&amp;s=9c1b8eda000475f357ed1b20009f4036a99a98aa" shape="rect"><img id="fig1_img" alt="thumbnail image" src="http://onlinelibrary.wiley.com/store/10.1002/ijc.1627/asset/image_t/tfig001.gif?v=1&amp;t=hlba7b63&amp;s=ef8ce728ab614aca4bfee27b3ba1a64c4ceb37f5" class="fc-figure-img" /></a><div class="caption" id="fig1_caption"><p><span class="label">Figure&nbsp;1. </span>Positive and negative predictive values of the logistic regression model.</p><p class="downloadToPowerpoint"><a href="/doi/10.1002/ijc.1627/figure.pptx?figureAssetHref=image_n/nfig001.gif" shape="rect">Download figure to PowerPoint</a></p></div></div></div></div><div class="section" id="sec1-3"><div class="headingCont"><h3>DISCUSSION</h3></div><ol class="jumpList"><li><a href="#leftBorder" shape="rect">Top of page</a></li><li><a href="#abstract" shape="rect">Abstract</a></li><li><a href="#sec1-1" shape="rect">MATERIAL AND METHODS</a></li><li><a href="#sec1-2" shape="rect">RESULTS</a></li><li><a href="#sec1-3" shape="rect">DISCUSSION</a></li><li><a href="#sec1-ack-1" shape="rect">Acknowledgements</a></li><li><a href="#wol-references" shape="rect">REFERENCES</a></li></ol><div class="para"><p>The aim of our study focused on Spanish breast/ovarian families was 2-fold: first, to define clinical criteria that may help to select which of these families must be referred for <em>BRCA1</em> and <em>BRCA2</em> genetic testing and, second, to study whether the prevalence of mutations and/or the spectrum of mutations in these genes may have implications for the design of a genetic testing protocol suited for these families.</p></div><div class="para"><p>We addressed all these questions by screening <em>BRCA1</em> and <em>BRCA2</em> mutation status in 102 Spanish breast and/or ovarian families and extensively studying the associated cancer phenotype. Most of these families did not have a very extensive history of cancer and are representative of families commonly seen at a genetic counselling clinic.</p></div><div class="para"><p>The prevalence of mutations that we have found in our families (30%) is within the range observed in mutation-based studies for other populations.<a href="#bib12" rel="references:#bib12" class="referenceLink" title="Link to bibliographic citation" shape="rect">12</a>, <a href="#bib14" rel="references:#bib14" class="referenceLink" title="Link to bibliographic citation" shape="rect">14</a>, <a href="#bib23" rel="references:#bib23 #bib24 #bib25 #bib26 #bib27" class="referenceLink" title="Link to bibliographic citations" shape="rect">23&ndash;27</a> The breast cancer linkage consortium (BCLC) estimates that 95% of breast/ovarian cancer families and 65% of female breast cancer families are related to <em>BRCA1</em> or <em>BRCA2</em>.<a href="#bib4" rel="references:#bib4" class="referenceLink" title="Link to bibliographic citation" shape="rect">4</a> We detected mutations in, respectively, 60% (8/13) and 23% (7/30) of our breast/ovarian and female breast cancer families with BCLC entry criteria (at least 4 breast cancer cases). The BCLC estimated that mutation screening methods found mutations in only 63% (95% CI 51&ndash;77%) of linked families.<a href="#bib4" rel="references:#bib4" class="referenceLink" title="Link to bibliographic citation" shape="rect">4</a> According to that, we estimate that in our population the prevalence of mutations in breast/ovarian families is in agreement with linkage-based predictions. By contrast, the prevalence of mutations in female breast cancer families seems to be lower. Further studies are needed to determine whether some mutations not detected with our current screening method (large genomic rearrangements or deletions) or mutations in other breast cancer susceptibility genes<a href="#bib4" rel="references:#bib4" class="referenceLink" title="Link to bibliographic citation" shape="rect">4</a> may explain a significant fraction of Spanish female breast cancer families.</p></div><div class="para"><p>We have found a significant excess of <em>BRCA1 vs. BRCA2</em> mutations (3-fold) in Spanish families with no male breast cancer cases recorded. This excess of <em>BRCA1</em> mutations is a common trait in many populations,<a href="#bib25" rel="references:#bib25" class="referenceLink" title="Link to bibliographic citation" shape="rect">25</a> although a similar prevalence for both genes<a href="#bib28" rel="references:#bib28" class="referenceLink" title="Link to bibliographic citation" shape="rect">28</a> or even an excess of <em>BRCA2</em> mutations<a href="#bib27" rel="references:#bib27" class="referenceLink" title="Link to bibliographic citation" shape="rect">27</a> has been described for some populations.</p></div><div class="para"><p>It has been suggested that <em>BRCA2</em> mutations are clustered in site-specific breast cancer families.<a href="#bib4" rel="references:#bib4" class="referenceLink" title="Link to bibliographic citation" shape="rect">4</a>, <a href="#bib27" rel="references:#bib27" class="referenceLink" title="Link to bibliographic citation" shape="rect">27</a>, <a href="#bib29" rel="references:#bib29" class="referenceLink" title="Link to bibliographic citation" shape="rect">29</a> This has been interpreted as evidence for an increase in ovarian cancer risk associated with <em>BRCA1</em> but not <em>BRCA2</em> mutations. Interestingly, 54% of Spanish <em>BRCA2</em>-related families identified in our study included cases of ovarian cancer. Some studies have postulated a <em>BRCA2</em> central region, the ovarian cancer cluster region (OCCR),<a href="#bib30" rel="references:#bib30" class="referenceLink" title="Link to bibliographic citation" shape="rect">30</a>, <a href="#bib31" rel="references:#bib31" class="referenceLink" title="Link to bibliographic citation" shape="rect">31</a> which is a target of mutations associated with a higher risk of developing ovarian cancer. However, this genotype-phenotype correlation doesn't explain our results because in our study, 1 of 3 families with OCCR mutations and 6 of 10 families with non-OCCR mutations have at least 1 ovarian cancer case. Other investigators also failed to demonstrate such an association.<a href="#bib24" rel="references:#bib24" class="referenceLink" title="Link to bibliographic citation" shape="rect">24</a>, <a href="#bib27" rel="references:#bib27" class="referenceLink" title="Link to bibliographic citation" shape="rect">27</a> It is possible that some mutations outside the OCCR region are also associated with an increase in ovarian cancer risk. Alternatively, other genetic or environmental factors present in the Spanish population may increase the ovarian cancer risk associated with a <em>BRCA2</em> mutation, but these associations require much larger sets of families to be discernible.</p></div><div class="para"><p>The data discussed above suggest that when male breast cancer cases are not present, <em>BRCA1</em> must be the first gene to be tested in Spanish families, regardless of whether these are breast or breast/ovarian families.</p></div><div class="para"><p>Several studies suggest a correlation between male breast cancer and <em>BRCA2</em> mutations,<a href="#bib29" rel="references:#bib29" class="referenceLink" title="Link to bibliographic citation" shape="rect">29</a> although the extent of this correlation is not clear. Linkage studies indicate that more than 80% of families with male breast cancer are related to <em>BRCA2</em> mutations.<a href="#bib4" rel="references:#bib4" class="referenceLink" title="Link to bibliographic citation" shape="rect">4</a>, <a href="#bib31" rel="references:#bib31" class="referenceLink" title="Link to bibliographic citation" shape="rect">31</a> Other studies identified <em>BRCA2</em> mutations in 50%<a href="#bib24" rel="references:#bib24" class="referenceLink" title="Link to bibliographic citation" shape="rect">24</a> or even only in 11% of these families.<a href="#bib32" rel="references:#bib32" class="referenceLink" title="Link to bibliographic citation" shape="rect">32</a> Moreover, one study did not find an association between male breast cancer and <em>BRCA2</em> status in a Dutch population.<a href="#bib33" rel="references:#bib33" class="referenceLink" title="Link to bibliographic citation" shape="rect">33</a> We found <em>BRCA2</em> mutations in all 5 families with male breast cancer, suggesting a strong association between these families and <em>BRCA2</em> mutations in the Spanish population. Indeed, in our study, male breast cancer was the only cancer phenotype that clearly distinguished <em>BRCA2</em> from <em>BRCA1</em> families. We think that <em>BRCA2</em> must be the first gene to be tested in Spanish families with male breast cancer.</p></div><div class="para"><p>We detected a statistically significant excess of families with prostate cancer cases in <em>BRCA1/2</em>-related families (4-fold). An increase of prostate incidence in both <em>BRCA1</em> and <em>BRCA2</em> carriers has been described, although the extent of this association has not been established definitively.<a href="#bib7" rel="references:#bib7" class="referenceLink" title="Link to bibliographic citation" shape="rect">7</a>, <a href="#bib29" rel="references:#bib29" class="referenceLink" title="Link to bibliographic citation" shape="rect">29</a> It is also interesting to note that we do not find an excess of cancer other than breast, ovarian and prostate in <em>BRCA</em>-positive families.</p></div><div class="para"><p>More than 500 different mutations have been described in <em>BRCA1</em> and <em>BRCA2</em> genes,<a href="#bib10" rel="references:#bib10" class="referenceLink" title="Link to bibliographic citation" shape="rect">10</a> but the number of different mutations in a defined population may be restricted. Specific populations for which recurrent mutations in <em>BRCA1</em> and <em>BRCA2</em> have been described include Scotland, The Netherlands and Belgium, Iceland, Finland, Russia, as well as French-Canadian and Ashkenazi populations.<a href="#bib5" rel="references:#bib5" class="referenceLink" title="Link to bibliographic citation" shape="rect">5</a>, <a href="#bib27" rel="references:#bib27" class="referenceLink" title="Link to bibliographic citation" shape="rect">27</a>, <a href="#bib30" rel="references:#bib30" class="referenceLink" title="Link to bibliographic citation" shape="rect">30</a>, <a href="#bib33" rel="references:#bib33 #bib34 #bib35" class="referenceLink" title="Link to bibliographic citations" shape="rect">33&ndash;35</a> Our study indicates that mutations 185delAG, 589delCT and Ala1708Glu may explain a significant fraction (63%) of <em>BRCA1</em>-related Spanish families. It may be recommendable to test the presence of these mutations as a first step of the screening protocol. Our study also suggests that most Spanish <em>BRCA1</em>-related families do not carry mutations located in exon 11. Although there is no obvious explanation for this observation, it may be efficient to analyse exon 11 in the final stage of the screening protocol.</p></div><div class="para"><p>Our analysis identified the number of ovarian cancer cases, the mean age at diagnosis of breast cancer, the presence of bilateral breast cancer, the presence of breast and ovarian cancer in a single woman and the presence of male breast cancer as major predictive factors for finding a mutation in a family. We have developed a logistic regression model that predicts the probability that a family carries a mutation in <em>BRCA1</em> or <em>BRCA2</em> as a function of these predictive factors. We think that this model may be a useful tool when deciding whether to refer a Spanish family to genetic testing or not. Like other studies, we have provided evidence for the predictive value of ovarian cancer and early onset of breast cancer,<a href="#bib11" rel="references:#bib11" class="referenceLink" title="Link to bibliographic citation" shape="rect">11</a>, <a href="#bib12" rel="references:#bib12" class="referenceLink" title="Link to bibliographic citation" shape="rect">12</a>, <a href="#bib24" rel="references:#bib24" class="referenceLink" title="Link to bibliographic citation" shape="rect">24</a> bilateral breast cancer<a href="#bib11" rel="references:#bib11" class="referenceLink" title="Link to bibliographic citation" shape="rect">11</a>, <a href="#bib24" rel="references:#bib24" class="referenceLink" title="Link to bibliographic citation" shape="rect">24</a> and breast and ovarian cancer in a single woman.<a href="#bib11" rel="references:#bib11" class="referenceLink" title="Link to bibliographic citation" shape="rect">11</a>, <a href="#bib12" rel="references:#bib12" class="referenceLink" title="Link to bibliographic citation" shape="rect">12</a> We did not find any predictive value for the number of unilateral breast cancer cases in the family. Others found either of low predictive value<a href="#bib11" rel="references:#bib11" class="referenceLink" title="Link to bibliographic citation" shape="rect">11</a> or of no predictive value at all.<a href="#bib12" rel="references:#bib12" class="referenceLink" title="Link to bibliographic citation" shape="rect">12</a> The latter study also failed to demonstrate a predictive value for the presence of bilateral breast cancer. In any case, a direct comparison of our model with previously published ones is difficult because these works were either restricted to <em>BRCA1</em><a href="#bib11" rel="references:#bib11" class="referenceLink" title="Link to bibliographic citation" shape="rect">11</a>, <a href="#bib12" rel="references:#bib12" class="referenceLink" title="Link to bibliographic citation" shape="rect">12</a> or analysed the cancer phenotype of the proband and not the family<a href="#bib24" rel="references:#bib24" class="referenceLink" title="Link to bibliographic citation" shape="rect">24</a> and, in general, had different clinical entry criteria.</p></div><div class="para"><p>Two recent studies present logistic regression models based on series of Finnish<a href="#bib15" rel="references:#bib15" class="referenceLink" title="Link to bibliographic citation" shape="rect">15</a> or Dutch<a href="#bib33" rel="references:#bib33" class="referenceLink" title="Link to bibliographic citation" shape="rect">33</a> families with 3 or more breast and/or ovarian cancer cases. The model by Vahteristo et al.<a href="#bib15" rel="references:#bib15" class="referenceLink" title="Link to bibliographic citation" shape="rect">15</a> includes the age of the youngest breast cancer patient and the number of ovarian cancers as the predictive variables and do not find a predictive value for female breast cancer, bilateral breast cancer or breast and ovarian cancer in a single woman. Male breast cancer is not considered. By contrast, the model by Peelen et al.<a href="#bib33" rel="references:#bib33" class="referenceLink" title="Link to bibliographic citation" shape="rect">33</a> includes the number of breast cancer patients, the mean age at diagnosis of breast cancer, the number of ovarian cancer patients and the presence of bilateral breast cancer as predictive variables. No predictive value is found for breast and ovarian cancer in a single woman or male breast cancer. Our predicting model includes the mean age at diagnosis of breast cancer, number of ovarian cancer patients and presence of bilateral breast cancer, breast and ovarian cancer in a single woman and male breast cancer as predictive variables. We do not find a predictive value for the number of female breast cancer cases. Thus, these 3 models show significant differences. Interestingly, both Finnish and Dutch populations exhibit different recurrent mutations in <em>BRCA1</em> and <em>BRCA2</em><a href="#bib15" rel="references:#bib15" class="referenceLink" title="Link to bibliographic citation" shape="rect">15</a>, <a href="#bib35" rel="references:#bib35" class="referenceLink" title="Link to bibliographic citation" shape="rect">35</a> and our study indicates the presence of other recurrent <em>BRCA1/2</em> mutations in the Spanish population. Possibly, different <em>BRCA1</em> and <em>BRCA2</em> mutation spectrums, together with different genetic and environmental factors, account for differences in the cancer phenotype of susceptible families, underscoring the relevance of predictive models specific for a given population.</p></div></div><div class="section" id="sec1-ack-1"><div class="headingCont"><h3>Acknowledgements</h3></div><ol class="jumpList"><li><a href="#leftBorder" shape="rect">Top of page</a></li><li><a href="#abstract" shape="rect">Abstract</a></li><li><a href="#sec1-1" shape="rect">MATERIAL AND METHODS</a></li><li><a href="#sec1-2" shape="rect">RESULTS</a></li><li><a href="#sec1-3" shape="rect">DISCUSSION</a></li><li><a href="#sec1-ack-1" shape="rect">Acknowledgements</a></li><li><a href="#wol-references" shape="rect">REFERENCES</a></li></ol><div class="para"><p>We thank the families for participating in our study. M.D.L.H. was supported by Fondo Investigacion Sanitaria (FIS) and UICC fellowship ICRETT 173/2000, A.O. is a fellow of Comunidad de Madrid, J.G. is a fellow of FIS and R.R. is a fellow of Asociaci&oacute;n Espa&ntilde;ola Contra el Cancer.</p></div></div><div id="wol-references" class="bibliography"><div class="headingCont"><h3>REFERENCES</h3></div><ol class="jumpList"><li><a href="#leftBorder" shape="rect">Top of page</a></li><li><a href="#abstract" shape="rect">Abstract</a></li><li><a href="#sec1-1" shape="rect">MATERIAL AND METHODS</a></li><li><a href="#sec1-2" shape="rect">RESULTS</a></li><li><a href="#sec1-3" shape="rect">DISCUSSION</a></li><li><a href="#sec1-ack-1" shape="rect">Acknowledgements</a></li><li><a href="#wol-references" shape="rect">REFERENCES</a></li></ol><ul class="custom"><li id="bib1"><span class="bullet">1</span><div class="text"><cite id="cit2"> <span class="author">Hall J</span>, <span class="author">Lee M</span>, <span class="author">Newman B</span>, et al. <span class="articleTitle">Linkage of early-onset familiar breast cancer to chromosome 17q21</span>. <span class="journalTitle">Science</span> <span class="pubYear">1991</span>;<span class="vol">250</span>: <span class="pageFirst">1684</span>&ndash;<span class="pageLast">9</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1126/science.2270482" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=2270482" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/ISI?id=A1990EN92000034" shape="rect">Web of Science&reg; Times Cited: 1375</a>,</li><li><a href="/resolve/reference/ADS?id=1990Sci...250.1684H" shape="rect">ADS</a></li></ul></div></li><li id="bib2"><span class="bullet">2</span><div class="text"><cite id="cit3"> <span class="author">Miki Y</span>, <span class="author">Swensen J</span>, <span class="author">Shattuck-Eidens D</span>, et al. <span class="articleTitle">A strong candidate for the breast and ovarian cancer susceptibility gene <em>BRCA1</em></span>. <span class="journalTitle">Science</span> <span class="pubYear">1994</span>;<span class="vol">266</span>: <span class="pageFirst">66</span>&ndash;<span class="pageLast">71</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1126/science.7545954" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=7545954" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK2MXhtF2ns70%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1994PK58200026" shape="rect">Web of Science&reg; Times Cited: 2982</a>,</li><li><a href="/resolve/reference/ADS?id=1994Sci...266...66M" shape="rect">ADS</a></li></ul></div></li><li id="bib3"><span class="bullet">3</span><div class="text"><cite id="cit4"> <span class="author">Wooster R</span>, <span class="author">Bignell G</span>, <span class="author">Lancaster J</span>, et al. <span class="articleTitle">Identification of the breast cancer susceptibility gene <em>BRCA2</em> to chromosome 13q12</span>. <span class="journalTitle">Science</span> <span class="pubYear">1995</span>;<span class="vol">265</span>: <span class="pageFirst">2088</span>&ndash;<span class="pageLast">90</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1126/science.8091231" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=8091231" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/ISI?id=A1994PJ91200028" shape="rect">Web of Science&reg; Times Cited: 975</a>,</li><li><a href="/resolve/reference/ADS?id=1994Sci...265.2088W" shape="rect">ADS</a></li></ul></div></li><li id="bib4"><span class="bullet">4</span><div class="text"><cite id="cit5"> <span class="author">Ford D</span>, <span class="author">Easton DF</span>, <span class="author">Stratton M</span>, et al. <span class="articleTitle">Genetic heterogeneity and penetrance analysis of the <em>BRCA1</em> and <em>BRCA2</em> genes in breast cancer gamilies</span>. <span class="journalTitle">Am J Hum Genet</span> <span class="pubYear">1998</span>;<span class="vol">62</span>: <span class="pageFirst">676</span>&ndash;<span class="pageLast">89</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1086/301749" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=9497246" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK1MXlvFeh" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=000072894400022" shape="rect">Web of Science&reg; Times Cited: 1239</a></li></ul></div></li><li id="bib5"><span class="bullet">5</span><div class="text"><cite id="cit6"> <span class="author">Szabo CI</span>, <span class="author">King M-C</span>. <span class="articleTitle">Population genetics of <em>BRCA1</em> and <em>BRCA2</em></span>. <span class="journalTitle">Am J Hum Genet</span> <span class="pubYear">1997</span>;<span class="vol">60</span>: <span class="pageFirst">1013</span>&ndash;<span class="pageLast">20</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/PMED?id=9150148" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:STN:280:DyaK2s3psVeqsA%3D%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1997WX76000001" shape="rect">Web of Science&reg; Times Cited: 326</a></li></ul></div></li><li id="bib6"><span class="bullet">6</span><div class="text"><cite id="cit7"> <span class="author">Ford D</span>, <span class="author">Easton D</span>, <span class="author">Bisho D</span>, et al. <span class="articleTitle">Risk of cancer in <em>BRCA1</em>-mutation carriers</span>. <span class="journalTitle">Lancet</span> <span class="pubYear">1994</span>;<span class="vol">343</span>: <span class="pageFirst">692</span>&ndash;<span class="pageLast">5</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1016/S0140-6736(94)91578-4" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=7907678" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:STN:280:DyaK2c7otVKitQ%3D%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1994NB80900007" shape="rect">Web of Science&reg; Times Cited: 994</a></li></ul></div></li><li id="bib7"><span class="bullet">7</span><div class="text"><cite id="cit8"> <span class="author">Struewing JP</span>, <span class="author">Hatge P</span>, <span class="author">Wacholder S</span>, et al. <span class="articleTitle">The risk of cancer associated with specific mutations of <em>BRCA1</em> and <em>BRCA2</em> among Ashkenazi Jews</span>. <span class="journalTitle">N Engl J Med</span> <span class="pubYear">1997</span>;<span class="vol">336</span>: <span class="pageFirst">1401</span>&ndash;<span class="pageLast">8</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1056/NEJM199705153362001" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=9145676" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:STN:280:DyaK2s3nsVShug%3D%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1997WY57700001" shape="rect">Web of Science&reg; Times Cited: 1092</a></li></ul></div></li><li id="bib8"><span class="bullet">8</span><div class="text"><cite id="cit9"> <span class="author">Easton DF</span>, <span class="author">Steele L</span>, <span class="author">Fields P</span>, et al. <span class="articleTitle">Cancer risks in two large breast cancer families linked to <em>BRCA2</em> on chromosome 13q12-13</span>. <span class="journalTitle">Am J Hum Genet</span> <span class="pubYear">1997</span>;<span class="vol">61</span>: <span class="pageFirst">120</span>&ndash;<span class="pageLast">8</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1086/513891" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=9245992" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:STN:280:DyaK2szovVOmuw%3D%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1997XM72800019" shape="rect">Web of Science&reg; Times Cited: 184</a></li></ul></div></li><li id="bib9"><span class="bullet">9</span><div class="text"><cite id="cit10"> <span class="author">Goggins M</span>, <span class="author">Schutte M</span>, <span class="author">Lu J</span>, et al. <span class="articleTitle">Germline <em>BRCA2</em> gene mutations in patients with apparently sporadic pancreatic carcinomas</span>. <span class="journalTitle">Cancer Res</span> <span class="pubYear">1996</span>;<span class="vol">56</span>: <span class="pageFirst">5360</span>&ndash;<span class="pageLast">4</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/PMED?id=8968085" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK28Xntl2mt74%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1996VV56200011" shape="rect">Web of Science&reg; Times Cited: 284</a></li></ul></div></li><li id="bib10"><span class="bullet">10</span><div class="text"><cite id="cit11"> <!--TODO: clickthrough URL--><a href="http://www.nchgr.nih.gov/Intramural_research/Lab_transfer/Bic/guidelines.html." title="Link to external resource: http://www.nchgr.nih.gov/Intramural_research/Lab_transfer/Bic/guidelines.html." shape="rect">www.nchgr.nih.gov/Intramural_research/Lab_transfer/Bic/guidelines.html</a>.</cite></div></li><li id="bib11"><span class="bullet">11</span><div class="text"><cite id="cit12"> <span class="author">Shattuck-Eidens D</span>, <span class="author">Oliphant A</span>, <span class="author">McClure M</span>, et al. <span class="articleTitle"><em>BRCA1</em> sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing and screening</span>. <span class="journalTitle">J Am Med Assoc</span> <span class="pubYear">1997</span>;<span class="vol">278</span>: <span class="pageFirst">1242</span>&ndash;<span class="pageLast">50</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1001/jama.278.15.1242" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=9333265" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK2sXmvFemtLk%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1997XZ70900029" shape="rect">Web of Science&reg; Times Cited: 262</a></li></ul></div></li><li id="bib12"><span class="bullet">12</span><div class="text"><cite id="cit13"> <span class="author">Couch FJ</span>, <span class="author">DeShano ML</span>, <span class="author">Blackwood MA</span>, et al. <span class="articleTitle"><em>BRCA1</em> mutations in women attending clinics that evaluate the risk of breast cancer</span>. <span class="journalTitle">N Engl J Med</span> <span class="pubYear">1997</span>;<span class="vol">336</span>: <span class="pageFirst">1409</span>&ndash;<span class="pageLast">15</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1056/NEJM199705153362002" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=9145677" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:STN:280:DyaK2s3nsVShuw%3D%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1997WY57700002" shape="rect">Web of Science&reg; Times Cited: 428</a></li></ul></div></li><li id="bib13"><span class="bullet">13</span><div class="text"><cite id="cit14"> <span class="author">Hodgson SV</span>, <span class="author">Heap E</span>, <span class="author">Cameron J</span>, et al. <span class="articleTitle">Risk factors for detecting germ-line <em>BRCA1</em> and <em>BRCA2</em> founder mutations in Ashkenazi Jewish women with breast or ovarian cancer</span>. <span class="journalTitle">J Med Genet</span> <span class="pubYear">1999</span>;<span class="vol">36</span>: <span class="pageFirst">369</span>&ndash;<span class="pageLast">73</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/PMED?id=10353781" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK1MXjslKlsr8%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=000080290700004" shape="rect">Web of Science&reg; Times Cited: 14</a></li></ul></div></li><li id="bib14"><span class="bullet">14</span><div class="text"><cite id="cit15"> <span class="author">Ligtenberg MJ</span>, <span class="author">Hogervorst FB</span>, <span class="author">Willems HW</span>, et al. <span class="articleTitle">Characteristics of small breast cancer and/or ovarian cancer families with germline mutations in <em>BRCA1</em> and <em>BRCA2</em></span>. <span class="journalTitle">Br J Cancer</span> <span class="pubYear">1999</span>;<span class="vol">79</span>: <span class="pageFirst">1475</span>&ndash;<span class="pageLast">8</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1038/sj.bjc.6690235" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=10188893" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:STN:280:DyaK1M3gt1OktA%3D%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=000079121100023" shape="rect">Web of Science&reg; Times Cited: 35</a></li></ul></div></li><li id="bib15"><span class="bullet">15</span><div class="text"><cite id="cit16"> <span class="author">Vahteristo P</span>, <span class="author">Eorola H</span>, <span class="author">Tamminen A</span>, et al. <span class="articleTitle">A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families</span>. <span class="journalTitle">Br J Cancer</span> <span class="pubYear">2001</span>;<span class="vol">84</span>: <span class="pageFirst">704</span>&ndash;<span class="pageLast">8</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1054/bjoc.2000.1626" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=11237395" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DC%2BD3MXisVeru7o%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=000167490900020" shape="rect">Web of Science&reg; Times Cited: 50</a></li></ul></div></li><li id="bib16"><span class="bullet">16</span><div class="text"><cite id="cit17"> <span class="author">D&iacute;ez O</span>, <span class="author">Osorio A</span>, <span class="author">Robledo M</span>, et al. <span class="articleTitle">Prevalence of <em>BRCA1</em> and <em>BRCA2</em> Jewish mutations in Spanish breast cancer patients</span>. <span class="journalTitle">Br J Cancer</span> <span class="pubYear">1999</span>;<span class="vol">79</span>: <span class="pageFirst">1302</span>&ndash;<span class="pageLast">3</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1038/sj.bjc.6690208" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=10098775" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/ISI?id=000078699500048" shape="rect">Web of Science&reg; Times Cited: 28</a></li></ul></div></li><li id="bib17"><span class="bullet">17</span><div class="text"><cite id="cit18"> <span class="author">Osorio A</span>, <span class="author">Barroso A</span>, <span class="author">Mart&iacute;nez B</span>, et al. <span class="articleTitle">Molecular analysis of the <em>BRCA1</em> and <em>BRCA2</em> genes in 32 breast and/or ovarian cancer Spanish families</span>. <span class="journalTitle">Br J Cancer</span> <span class="pubYear">2000</span>;<span class="vol">82</span>: <span class="pageFirst">1266</span>&ndash;<span class="pageLast">70</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1054/bjoc.1999.1089" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=10755399" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXisFOntb8%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=000085917800005" shape="rect">Web of Science&reg; Times Cited: 50</a></li></ul></div></li><li id="bib18"><span class="bullet">18</span><div class="text"><cite id="cit19"> <span class="author">De La Hoya M</span>, <span class="author">P&eacute;rez-Segura P</span>, <span class="author">Van Orsouw N</span>, et al. <span class="articleTitle">Spanish family study on hereditary breast and/or ovarian cancer: analysis of the <em>BRCA1</em> gene</span>. <span class="journalTitle">Int J Cancer</span> <span class="pubYear">2001</span>; <span class="vol">91</span>: <span class="pageFirst">137</span>&ndash;<span class="pageLast">40</span>.</cite><div class="internalReferences"><div><span class="directLinkLabel">Direct Link:</span></div><ul><li><a href="/doi/10.1002/1097-0215(20010101)91:1&lt;137::AID-IJC1020&gt;3.0.CO;2-R/abstract" shape="rect">Abstract</a></li><li><a href="/doi/10.1002/1097-0215(20010101)91:1&lt;137::AID-IJC1020&gt;3.0.CO;2-R/full" shape="rect">Full Article (HTML)</a></li><li><a href="/doi/10.1002/1097-0215(20010101)91:1&lt;137::AID-IJC1020&gt;3.0.CO;2-R/pdf" shape="rect">PDF(45K)</a></li><li><a href="/resolve/reference/ISI?id=000165619800019" shape="rect">Web of Science&reg; Times Cited: 17</a></li></ul></div></div></li><li id="bib19"><span class="bullet">19</span><div class="text"><cite id="cit20"> <span class="author">Ganguly T</span>, <span class="author">Dhulipala R</span>, <span class="author">Godmiliw L</span>, et al. <span class="articleTitle">High throughput fluorescent-based conformation sensitive gel electrophoresis (F-CSGE) identifies six unique <em>BRCA2</em> mutations and an overall low incidence of <em>BRCA2</em> mutations in high-risk <em>BRCA1</em>-negative breast cancer families</span>. <span class="journalTitle">Hum Gent</span> <span class="pubYear">1998</span>;<span class="vol">102</span>: <span class="pageFirst">549</span>&ndash;<span class="pageLast">56</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1007/s004390050738" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=9654203" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK1cXjtF2hs70%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=000074171100007" shape="rect">Web of Science&reg; Times Cited: 30</a></li></ul></div></li><li id="bib20"><span class="bullet">20</span><div class="text"><cite id="cit21"> <span class="author">Struewing JP</span>, <span class="author">Abeliovich D</span>, <span class="author">Peretz T</span>, et al. <span class="articleTitle">The carrier frequency of the <em>BRCA1</em> 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals</span>. <span class="journalTitle">Nat Genet</span> <span class="pubYear">1995</span>;<span class="vol">11</span>: <span class="pageFirst">198</span>&ndash;<span class="pageLast">200</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1038/ng1095-198" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=7550349" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK2MXosF2rtrc%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1995RX80600023" shape="rect">Web of Science&reg; Times Cited: 428</a></li></ul></div></li><li id="bib21"><span class="bullet">21</span><div class="text"><cite id="cit22"> <span class="author">Chapman MS</span>, <span class="author">Verma IM</span>. <span class="articleTitle">Transcriptional activation by <em>BRCA1</em></span>. <span class="journalTitle">Nature</span> <span class="pubYear">1996</span>;<span class="vol">382</span>: <span class="pageFirst">678</span>&ndash;<span class="pageLast">9</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1038/382678a0" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=8751436" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK28Xlt1ylsbg%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1996VD33300034" shape="rect">Web of Science&reg; Times Cited: 362</a>,</li><li><a href="/resolve/reference/ADS?id=1996Natur.382..678C" shape="rect">ADS</a></li></ul></div></li><li id="bib22"><span class="bullet">22</span><div class="text"><cite id="cit23"> <span class="author">Vallo-Christersson J</span>, <span class="author">Cayanan C</span>, <span class="author">Haraldsson L</span>, et al. <span class="articleTitle">Functional analysis of <em>BRCA1</em> C-terminal missense mutations identified in breast and ovarian cancer families</span>. <span class="journalTitle">Hum Mol Genet</span> <span class="pubYear">2001</span>;<span class="vol">10</span>: <span class="pageFirst">353</span>&ndash;<span class="pageLast">60</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1093/hmg/10.4.353" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=11157798" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/ISI?id=000167087800005" shape="rect">Web of Science&reg; Times Cited: 79</a></li></ul></div></li><li id="bib23"><span class="bullet">23</span><div class="text"><cite id="cit24"> <span class="author">Peto J</span>, <span class="author">Collins N</span>, <span class="author">Barfoot R</span>, et al. <span class="articleTitle">Prevalence of BRCA1 and BRCA2 gene mutations in patients with early onset breast cancer</span>. <span class="journalTitle">J Natl Cancer Inst</span> <span class="pubYear">1999</span>;<span class="vol">91</span>: <span class="pageFirst">943</span>&ndash;<span class="pageLast">9</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1093/jnci/91.11.943" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=10359546" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK1MXjvFOmtb4%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=000080680600010" shape="rect">Web of Science&reg; Times Cited: 339</a></li></ul></div></li><li id="bib24"><span class="bullet">24</span><div class="text"><cite id="cit25"> <span class="author">Frank TS</span>, <span class="author">Manley SA</span>, <span class="author">Olopade OI</span>, et al. <span class="articleTitle">Sequence analysis of <em>BRCA1</em> and <em>BRCA2</em>: correlation of mutations with family history and ovarian cancer risk</span>. <span class="journalTitle">J Clin Oncol</span> <span class="pubYear">1998</span>;<span class="vol">16</span>: <span class="pageFirst">2417</span>&ndash;<span class="pageLast">25</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/PMED?id=9667259" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK1cXks1Gntbo%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=000074596200019" shape="rect">Web of Science&reg; Times Cited: 237</a></li></ul></div></li><li id="bib25"><span class="bullet">25</span><div class="text"><cite id="cit26"> <span class="author">Wagner TMU</span>, <span class="author">Moslinger RA</span>, <span class="author">Muhr D</span>, et al. <span class="articleTitle"><em>BRCA1</em>-related breast cancer in Austrian breast and ovarian cancer families: specific <em>BRCA1</em> mutations and pathological characteristics</span>. <span class="journalTitle">Int J Cancer</span> <span class="pubYear">1998</span>;<span class="vol">77</span>: <span class="pageFirst">354</span>&ndash;<span class="pageLast">60</span>.</cite><div class="internalReferences"><div><span class="directLinkLabel">Direct Link:</span></div><ul><li><a href="/doi/10.1002/(SICI)1097-0215(19980729)77:3&lt;354::AID-IJC8&gt;3.0.CO;2-N/abstract" shape="rect">Abstract</a></li><li><a href="/doi/10.1002/(SICI)1097-0215(19980729)77:3&lt;354::AID-IJC8&gt;3.0.CO;2-N/pdf" shape="rect">PDF(76K)</a></li><li><a href="/doi/10.1002/(SICI)1097-0215(19980729)77:3&lt;354::AID-IJC8&gt;3.0.CO;2-N/references" shape="rect">References</a></li><li><a href="/resolve/reference/ISI?id=000074420300008" shape="rect">Web of Science&reg; Times Cited: 63</a></li></ul></div></div></li><li id="bib26"><span class="bullet">26</span><div class="text"><cite id="cit27"> <span class="author">Wagner TMU</span>, <span class="author">Hirtenlehner K</span>, <span class="author">Shen PD</span>, et al. <span class="articleTitle">Global sequence diversity of <em>BRCA2</em>: analysis of 71 breast cancer families and 95 control individuals of worldwide population</span>. <span class="journalTitle">Hum Mol Genet</span> <span class="pubYear">1999</span>;<span class="vol">8</span>: <span class="pageFirst">413</span>&ndash;<span class="pageLast">23</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1093/hmg/8.3.413" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=9971877" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK1MXhslKnt7o%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=000079000100004" shape="rect">Web of Science&reg; Times Cited: 69</a></li></ul></div></li><li id="bib27"><span class="bullet">27</span><div class="text"><cite id="cit28"> <span class="author">Ikeda N</span>, <span class="author">Miyoshi Y</span>, <span class="author">Yoneda K</span>, et al. <span class="articleTitle">Frequency of <em>BRCA1</em> and <em>BRCA2</em> germline mutations in Japanese breast cancer families</span>. <span class="journalTitle">Int J Cancer</span> <span class="pubYear">2001</span>;<span class="vol">91</span>: <span class="pageFirst">83</span>&ndash;<span class="pageLast">8</span>.</cite><div class="internalReferences"><div><span class="directLinkLabel">Direct Link:</span></div><ul><li><a href="/doi/10.1002/1097-0215(20010101)91:1&lt;83::AID-IJC1013&gt;3.0.CO;2-5/abstract" shape="rect">Abstract</a></li><li><a href="/doi/10.1002/1097-0215(20010101)91:1&lt;83::AID-IJC1013&gt;3.0.CO;2-5/full" shape="rect">Full Article (HTML)</a></li><li><a href="/doi/10.1002/1097-0215(20010101)91:1&lt;83::AID-IJC1013&gt;3.0.CO;2-5/pdf" shape="rect">PDF(71K)</a></li><li><a href="/doi/10.1002/1097-0215(20010101)91:1&lt;83::AID-IJC1013&gt;3.0.CO;2-5/references" shape="rect">References</a></li><li><a href="/resolve/reference/ISI?id=000165619800012" shape="rect">Web of Science&reg; Times Cited: 34</a></li></ul></div></div></li><li id="bib28"><span class="bullet">28</span><div class="text"><cite id="cit29"> <span class="author">Vehmanen P</span>, <span class="author">Friedman LS</span>, <span class="author">Eerola H</span>, et al. <span class="articleTitle">A low proportion of <em>BRCA2</em> mutations in Finnish breast cancer families</span>. <span class="journalTitle">Am J Hum Genet</span> <span class="pubYear">1997</span>;<span class="vol">60</span>: <span class="pageFirst">1050</span>&ndash;<span class="pageLast">8</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/PMED?id=9150152" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:STN:280:DyaK2s3psVeqtA%3D%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1997WX76000005" shape="rect">Web of Science&reg; Times Cited: 55</a></li></ul></div></li><li id="bib29"><span class="bullet">29</span><div class="text"><cite id="cit30"> <span class="author">Ellisen LW</span>, <span class="author">Haber DH</span>. <span class="articleTitle">Hereditary breast cancer</span>. <span class="journalTitle">Annu Rev Med</span> <span class="pubYear">1998</span>;<span class="vol">49</span>: <span class="pageFirst">425</span>&ndash;<span class="pageLast">36</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1146/annurev.med.49.1.425" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=9509273" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK1cXhtFKqtL4%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=000073046600028" shape="rect">Web of Science&reg; Times Cited: 35</a></li></ul></div></li><li id="bib30"><span class="bullet">30</span><div class="text"><cite id="cit31"> <span class="author">Gayther SA</span>, <span class="author">Mangion J</span>, <span class="author">Russell P</span>, et al. <span class="pubYear">1997</span>. <span class="articleTitle">Variation of risks of breast and ovarian cancer associated with different germ-line mutations of the <em>BRCA2</em> gene</span>. <span class="journalTitle">Nat Genet</span> 1997;<span class="vol">15</span>: <span class="pageFirst">103</span>&ndash;<span class="pageLast">5</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1038/ng0197-103" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=8988179" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK2sXjsFKjsQ%3D%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1997WA37300031" shape="rect">Web of Science&reg; Times Cited: 253</a></li></ul></div></li><li id="bib31"><span class="bullet">31</span><div class="text"><cite id="cit32"> <span class="author">Thompson D</span>, <span class="author">Easton D</span>. <span class="pubYear">2001</span>. <span class="articleTitle">Variation in cancer risks, by mutation position, in <em>BRCA2</em> mutation carriers</span>. <span class="journalTitle">Am J Hum Genet</span> 2001;<span class="vol">68</span>: <span class="pageFirst">410</span>&ndash;<span class="pageLast">1</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1086/318181" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=11170890" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DC%2BD3MXhtl2lsLs%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=000166524800011" shape="rect">Web of Science&reg; Times Cited: 157</a></li></ul></div></li><li id="bib32"><span class="bullet">32</span><div class="text"><cite id="cit33"> <span class="author">Friedman LS</span>, <span class="author">Gayther SA</span>, <span class="author">Kurosaki T</span>, et al. <span class="articleTitle">Mutation analysis of <em>BRCA1</em> and <em>BRCA2</em> in a male breast cancer population</span>. <span class="journalTitle">Am J Hum Genet</span> <span class="pubYear">1997</span>;<span class="vol">60</span>: <span class="pageFirst">313</span>&ndash;<span class="pageLast">9</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/PMED?id=9012404" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK2sXhtVCju70%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1997WE93100010" shape="rect">Web of Science&reg; Times Cited: 127</a></li></ul></div></li><li id="bib33"><span class="bullet">33</span><div class="text"><cite id="cit34"> <span class="author">Peelen T</span>. <span class="otherTitle">Genetics of hereditary breast and ovarian cancer in the Netherlands</span>. PhD thesis. Leiden, The Netherlands: Leiden University, <span class="pubYear">2001</span>. <span class="pageFirst">122</span>&ndash;<span class="pageLast">3</span>.</cite></div></li><li id="bib34"><span class="bullet">34</span><div class="text"><cite id="cit35"> <span class="author">Liede A</span>, <span class="author">Cohen B</span>, <span class="author">Black DM</span>, et al. <span class="articleTitle">Evidence of a founder <em>BRCA1</em> mutation in Scotland</span>. <span class="journalTitle">Br J Cancer</span> <span class="pubYear">2000</span>;<span class="vol">82</span>: <span class="pageFirst">705</span>&ndash;<span class="pageLast">11</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/PMED?id=10682686" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:STN:280:DC%2BD3c7ksVyqsw%3D%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=000085031700031" shape="rect">Web of Science&reg; Times Cited: 16</a></li></ul></div></li><li id="bib35"><span class="bullet">35</span><div class="text"><cite id="cit36"> <span class="author">Tonin PN</span>, <span class="author">Mesmasson AM</span>, <span class="author">Futreal PA</span>, et al. <span class="articleTitle">Founder <em>BRCA1</em> and <em>BRCA2</em> mutations in French Canadian breast and ovarian cancer families</span>. <span class="journalTitle">Am J Hum Genet</span> <span class="pubYear">1998</span>;<span class="vol">63</span>: <span class="pageFirst">1341</span>&ndash;<span class="pageLast">51</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/XREF?id=10.1086/302099" shape="rect">CrossRef</a>,</li><li><a href="/resolve/reference/PMED?id=9792861" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:STN:280:DyaK1M%2FhtFamtg%3D%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=000076985200010" shape="rect">Web of Science&reg; Times Cited: 81</a></li></ul></div></li><li id="bib36"><span class="bullet">36</span><div class="text"><cite id="cit37"> <span class="author">Peelen T</span>, <span class="author">van Vliet M</span>, <span class="author">Petriuj-Bosch A</span>, et al. <span class="articleTitle">A high proportion of novel mutations in <em>BRCA1</em> with strong founder effects among Dutch and Belgian hereditary breast and ovarian families</span>. <span class="journalTitle">Am J Hum Genet</span> <span class="pubYear">1997</span>;<span class="vol">60</span>: <span class="pageFirst">1041</span>&ndash;<span class="pageLast">9</span>.</cite><ul class="externalReferences"><li><a href="/resolve/reference/PMED?id=9150151" shape="rect">PubMed</a>,</li><li><a href="/resolve/reference/CAS?id=1:CAS:528:DyaK2sXjtlOqsr8%3D" shape="rect">CAS</a>,</li><li><a href="/resolve/reference/ISI?id=A1997WX76000004" shape="rect">Web of Science&reg; Times Cited: 110</a></li></ul></div></li></ul></div><style xml:space="preserve">
 .overlined {
 text-decoration: overline;
 }
 .struck {
 text-decoration:line-through;
 }
 .underlined {
 text-decoration:underline;
 }
 .doubleUnderlined {
 text-decoration:underline;border-bottom:1px solid #000;
 }
 </style></div> <div xmlns:doc="urn://wiley-online-library/content/document" xmlns="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" class="viewFullArticleAndPdf"><div class="viewFullArticleAndPdfOptions"><a href="/doi/10.1002/ijc.1627/pdf" title="Article in pdf format" class="pdfLink" shape="rect">Get PDF (86K)</a></div></div> <div id="relatedArticles"> <div class="sectionHeading"> <h3>More content like this</h3> </div> <span id="findArticlesHeading">Find more content:</span> <ul class="findArticles"><li><a href="/advanced/search/results?articleDoi=10.1002/ijc.1627&amp;scope=allContent&amp;start=1&amp;resultsPerPage=20" title="Link to articles like this" shape="rect">like this article</a></li></ul> <span xmlns="http://www.w3.org/1999/xhtml" id="articlesWrittenByHeading">Find more content written by:</span><ul xmlns="http://www.w3.org/1999/xhtml" class="articlesWrittenBy"><li><a title="Link to more articles by Miguel de la Hoya" href="/advanced/search/results?searchRowCriteria[0].queryString=&quot;Miguel de la Hoya&quot;&amp;searchRowCriteria[0].fieldName=author&amp;start=1&amp;resultsPerPage=20" shape="rect">Miguel de la Hoya</a></li><li><a title="Link to more articles by Ana Osorio" href="/advanced/search/results?searchRowCriteria[0].queryString=&quot;Ana Osorio&quot;&amp;searchRowCriteria[0].fieldName=author&amp;start=1&amp;resultsPerPage=20" shape="rect">Ana Osorio</a></li><li><a title="Link to more articles by Javier Godino" href="/advanced/search/results?searchRowCriteria[0].queryString=&quot;Javier Godino&quot;&amp;searchRowCriteria[0].fieldName=author&amp;start=1&amp;resultsPerPage=20" shape="rect">Javier Godino</a></li><li><a title="Link to more articles by Sara Sulleiro" href="/advanced/search/results?searchRowCriteria[0].queryString=&quot;Sara Sulleiro&quot;&amp;searchRowCriteria[0].fieldName=author&amp;start=1&amp;resultsPerPage=20" shape="rect">Sara Sulleiro</a></li><li><a title="Link to more articles by Alicia Tosar" href="/advanced/search/results?searchRowCriteria[0].queryString=&quot;Alicia Tosar&quot;&amp;searchRowCriteria[0].fieldName=author&amp;start=1&amp;resultsPerPage=20" shape="rect">Alicia Tosar</a></li><li><a title="Link to more articles by Pedro Perez&#x2010;Segura" href="/advanced/search/results?searchRowCriteria[0].queryString=&quot;Pedro Perez-Segura&quot;&amp;searchRowCriteria[0].fieldName=author&amp;start=1&amp;resultsPerPage=20" shape="rect">Pedro Perez-Segura</a></li><li><a title="Link to more articles by Cristina Fernandez" href="/advanced/search/results?searchRowCriteria[0].queryString=&quot;Cristina Fernandez&quot;&amp;searchRowCriteria[0].fieldName=author&amp;start=1&amp;resultsPerPage=20" shape="rect">Cristina Fernandez</a></li><li><a title="Link to more articles by Raquel Rodr&iacute;guez" href="/advanced/search/results?searchRowCriteria[0].queryString=&quot;Raquel Rodr%C3%ADguez&quot;&amp;searchRowCriteria[0].fieldName=author&amp;start=1&amp;resultsPerPage=20" shape="rect">Raquel Rodr&iacute;guez</a></li><li><a title="Link to more articles by Eduardo D&iacute;az&#x2010;Rubio" href="/advanced/search/results?searchRowCriteria[0].queryString=&quot;Eduardo D%C3%ADaz-Rubio&quot;&amp;searchRowCriteria[0].fieldName=author&amp;start=1&amp;resultsPerPage=20" shape="rect">Eduardo D&iacute;az-Rubio</a></li><li><a title="Link to more articles by Javier Ben&iacute;tez" href="/advanced/search/results?searchRowCriteria[0].queryString=&quot;Javier Ben%C3%ADtez&quot;&amp;searchRowCriteria[0].fieldName=author&amp;start=1&amp;resultsPerPage=20" shape="rect">Javier Ben&iacute;tez</a></li><li><a title="Link to more articles by Peter Devilee" href="/advanced/search/results?searchRowCriteria[0].queryString=&quot;Peter Devilee&quot;&amp;searchRowCriteria[0].fieldName=author&amp;start=1&amp;resultsPerPage=20" shape="rect">Peter Devilee</a></li><li><a title="Link to more articles by Trinidad Cald&eacute;s" href="/advanced/search/results?searchRowCriteria[0].queryString=&quot;Trinidad Cald%C3%A9s&quot;&amp;searchRowCriteria[0].fieldName=author&amp;start=1&amp;resultsPerPage=20" shape="rect">Trinidad Cald&eacute;s</a></li><li class="lastItem"><a title="Link to more articles by the present authors" href="/advanced/search/results?searchRowCriteria[0].queryString=&quot;Miguel de la Hoya&quot; &quot;Ana Osorio&quot; &quot;Javier Godino&quot; &quot;Sara Sulleiro&quot; &quot;Alicia Tosar&quot; &quot;Pedro Perez-Segura&quot; &quot;Cristina Fernandez&quot; &quot;Raquel Rodr%C3%ADguez&quot; &quot;Eduardo D%C3%ADaz-Rubio&quot; &quot;Javier Ben%C3%ADtez&quot; &quot;Peter Devilee&quot; &quot;Trinidad Cald%C3%A9s&quot;&amp;searchRowCriteria[0].fieldName=author&amp;start=1&amp;resultsPerPage=20" shape="rect">All Authors</a></li></ul> </div> </div> </div> <div id="footer"> <div id="indexBottomLeftCorner"></div> <div id="indexBottomRightCorner"></div> <ul><li><a href="http://olabout.wiley.com/WileyCDA/Section/id-390001.html" shape="rect">ABOUT US</a></li><li><a href="http://onlinelibrary.custhelp.com/" shape="rect">HELP</a></li><li><a href="http://olabout.wiley.com/WileyCDA/Section/id-397203.html" shape="rect">CONTACT US</a></li><li><a href="http://olabout.wiley.com/WileyCDA/Section/id-390243.html" shape="rect">AGENTS</a></li><li><a href="http://olabout.wiley.com/WileyCDA/Section/id-390236.html" shape="rect">ADVERTISERS</a></li><li><a href="http://olabout.wiley.com/WileyCDA/Section/id-390242.html" shape="rect">MEDIA</a></li><li><a href="/privacyPolicy" shape="rect">PRIVACY</a></li><li><a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html" shape="rect">COOKIES</a></li><li><a href="/termsAndConditions" shape="rect">TERMS &amp; CONDITIONS</a></li><li><a href="/siteMap" shape="rect">SITE MAP</a></li></ul> <p>Copyright &copy; 1999&ndash;2013 John Wiley &amp; Sons, Inc. All Rights Reserved.</p> </div> <!-- START Site Catalyst --> <!-- SiteCatalyst code version: H.20.3. --> <script language="JavaScript" type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/s_code_wileyonlinelibrary-production.js" xml:space="preserve"></script><script language="JavaScript" type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/wol.siteCatalyst.js" xml:space="preserve"></script><script language="JavaScript" type="text/javascript" xml:space="preserve">siteCatalyst.init();
 <!--/* You may give each page an identifying name, server, and channel on the next lines. */
 s.channel="JOURNALS"
 s.events="event12"
 s.pageName=""
 s.prop1="FULLTEXT"
 s.prop10="Subscription"
 s.prop11="PDF and HTML"
 s.prop12="4342"
 s.prop13="10.1002/(ISSN)1097-0215"
 s.prop14="10.1002/ijc.1627"
 s.prop15="10.1002/ijc.v97:4"
 s.prop18="18 OCT 2001"
 s.prop2="FULLTEXT_HTML"
 s.prop20=""
 s.prop26="Guest"
 s.prop28=""
 s.prop3="International Journal of Cancer"
 s.prop4="MDH0,LS30,MDC0,MDH2,MDH3,MDH4,MDK0,MDM1"
 s.prop5=""
 s.prop6=""
 s.prop7="Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast\/ovarian cancer families: Implications for genetic testing"
 s.prop8="97/4"
 s.prop9="Delayed Free"
 s.server="onlinelibrary.wiley.com"
 /************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
 var s_code=s.t();if(s_code)document.write(s_code)//--></script> <script language="JavaScript" type="text/javascript" xml:space="preserve"><!--if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-')//--></script> <noscript><a href="http://www.omniture.com" title="Web Analytics" shape="rect"><img src="http://wileypublishing.112.2o7.net/b/ss/wileyonlinelibrary-production/1/H.20.3--NS/0?[AQB]&amp;cdp=3&amp;[AQE]" height="1" width="1" border="0" alt="" /></a></noscript><!--/DO NOT REMOVE/--> <!-- End SiteCatalyst code version: H.20.3. --> <!-- END Site Catalyst --> <!-- Start Google Analytics --> <script type="text/javascript" xml:space="preserve">
 var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
 document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
 </script> <script type="text/javascript" xml:space="preserve">
 try {
 var pageTracker = _gat._getTracker("UA-11972776-3");
 pageTracker._trackPageview();
 } catch(err) {}</script> <!-- End Google Analytics --> </div> </div><script type="text/javascript" xml:space="preserve">
 (function (wol) {
 wol.config = wol.config || {};

 wol.config.staticAssetUrl = 'http://onlinelibrarystatic.wiley.com/';

 return wol;
 }(window.wol = window.wol || {}));

 </script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery/jquery-1.4.2.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery-ui/jquery.ui.core.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery-ui/jquery.ui.widget.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery-ui/jquery.ui.position.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery-ui/jquery.ui.autocomplete.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/ol.widgets.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery/jquery.cookie.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/wol.analytics.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery/jquery.bgiframe.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery.fancybox-1.3.1.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery.scrollTo-1.4.2-min.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery.easing-1.3.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery.mousewheel.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/wol.fancybox.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/json2.min.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery/jquery.flot.js" xml:space="preserve"></script><!--[if IE]><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/excanvas.js"></script><![endif]--><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/wol.metrics.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/wol.jquery.plugins.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/wol.siteCatalystTL.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/wol.treeListMenu.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/wol.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery/jquery.validate.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/wol.login.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/jquery/jquery.validate.js" xml:space="preserve"></script><script type="text/javascript" src="http://onlinelibrarystatic.wiley.com/js/wol.login.js" xml:space="preserve"></script></body></html>
